All conditions

Heart Disease

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

5576
Trials on record
624
Recruiting now
14
Australian sites
40
Phase 3 trials
14
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Heart Disease →

Get alerts when Heart Disease trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Heart Disease

Heart disease is a broad term used to describe a range of conditions that affect how the heart works. The most common type in Australia is coronary artery disease, where the blood vessels that supply the heart become narrowed or blocked, making it harder for the heart to do its job properly. Other forms include heart failure, where the heart cannot pump blood as efficiently as it should, and conditions affecting the heart's rhythm or valves. In many cases, heart disease develops gradually over time and may not cause obvious symptoms in the early stages.

Heart disease is one of the most common serious health conditions in Australia, affecting hundreds of thousands of people across the country. It does not discriminate — it affects men and women, though it can present differently between them, and it becomes more common as people get older. Certain groups, including Aboriginal and Torres Strait Islander peoples, have higher rates of heart disease, often at younger ages. Having risk factors such as high blood pressure, high cholesterol, diabetes, smoking, or a family history of heart problems can increase a person's likelihood of developing the condition.

When it comes to managing heart disease, there are generally several approaches that doctors consider depending on the type and severity of the condition. These commonly include lifestyle changes around diet, physical activity, and smoking, as well as medications to help manage symptoms and reduce risk. In some situations, procedures or surgery may be recommended to improve blood flow or address specific problems with the heart. A team of health professionals — including GPs, cardiologists, and cardiac nurses — are typically involved in supporting people with heart disease over time.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Heart Disease in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for Heart Disease

14 medicines listed on the PBS for Heart Disease. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 14 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
Dapagliflozin Forxiga heart failure AU$36.42 Streamlined authority
Empagliflozin Jardiance heart failure AU$39.02 Streamlined authority
Eplerenone Inpler heart failure AU$37.79 Streamlined authority
Ivabradine Coralan heart failure AU$31.03 Streamlined authority
Sacubitril + valsartan Entresto heart failure AU$80.73 Streamlined authority
Vericiguat Verquvo heart failure AU$120.4 Authority required
Bisoprolol Bisoprolol generichealth heart failure Moderate to severe AU$4 Restricted benefit
Carvedilol Vedilol 3.125, Dilatrend 6.25, Dilatrend 12.5 +1 more heart failure Moderate to severe AU$3.33 Restricted benefit
METOPROLOL SUCCINATE Metrol-XL 23.75, Metrol-XL 47.5, Metrol-XL 95 +1 more heart failure Moderate to severe AU$4 Restricted benefit
Nebivolol APO-Nebivolol, Nebilet heart failure Moderate to severe AU$8.59 Restricted benefit
Prasugrel Prasugrel Lupin Acute coronary syndrome (myocardial infarction or unstable angina) AU$47.25 Streamlined authority
Ticagrelor ARX-TICAGRELOR Acute coronary syndrome (myocardial infarction or unstable angina) AU$81.59 Streamlined authority
Bivalirudin BIVALIRUDIN ARX Coronary artery disease AU$413.89 Streamlined authority
Tirofiban Aggrastat Non-Q-wave myocardial infarction AU$155.09 Streamlined authority

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for Heart Disease currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Heart Disease.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Heart Disease by country. Australia is highlighted.

Showing the top 10 of 75 countries with trial sites.

Clinical trials for Heart Disease

Showing 627 of 627 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT01498692 · Boston Scientific Corporation Not Applicable · 6 countries Completed
Completed Not Applicable Est. completion 1 December 2010
🇦🇺 AU🇧🇪 BE🇫🇷 FR🇯🇵 JP🇳🇿 NZ🇺🇸 US

**Who might be able to join this trial:** - People who are at least 18 years old - People (or their legal guardian) who understand what the study involves and have given written consent before any study-related tests begin - People under 20 years old enrolling at a site in Japan, where both the patient and their legal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT01500434 · Boston Scientific Corporation Phase 3 · 7 countries Completed
Completed Phase 3 Est. completion 1 March 2011
🇦🇺 AU🇧🇪 BE🇫🇷 FR🇯🇵 JP🇱🇻 LV🇳🇿 NZ🇺🇸 US

**Who might be able to join this trial:** - People who are at least 18 years old - People (or their legal guardian) who understand what the study involves and agree in writing before any study tests begin - People being enrolled at a Japanese site who are under 20 years old must have both their own written consent and...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT01663402 · Sanofi Phase 3 · 57 countries Completed
Completed Phase 3 Est. completion 23 January 2018
🇦🇷 AR🇦🇺 AU🇦🇹 AT🇧🇪 BE Bosnia and Herzegovina🇧🇷 BR🇧🇬 BG🇨🇦 CA +49 more

**Who might be able to join this trial:** - You were hospitalised in the last 52 weeks (about one year) for a serious heart condition called Acute Coronary Syndrome (ACS), which includes events like a heart attack or severe chest pain caused by blocked arteries. **Who may not be able to join:** - You are younger than...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT03998319 · University of Sydney Phase 3 · 2 countries Recruiting
Recruiting Phase 3 Est. completion 31 December 2024
🇦🇺 AU🇳🇿 NZ

Who might be able to join this trial: - Adults aged 18 or older who have had a specific type of heart attack (called a STEMI) and arrived for treatment within 6 hours of symptoms starting, with at least 20 minutes of chest pain or shortness of breath and a confirmed abnormal heart tracing (ECG) matching Australian Nati...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT04124120 · Weill Medical College of Cornell University Not Applicable · 26 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2030
🇦🇺 AU🇦🇹 AT🇧🇷 BR🇨🇦 CA🇨🇳 CN🇭🇷 HR🇨🇿 CZ🇩🇰 DK +18 more

**Who might be able to join this trial:** - Women aged 18 or older - People having coronary artery bypass grafting (a type of heart surgery to improve blood flow) as the only procedure being performed - People having this type of heart surgery for the first time - People with significant blockage or disease in specifi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT04983823 · Baker Heart and Diabetes Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2025
🇦🇺 AU

Who might be able to join this trial: - People who have previously had a COVID-19 infection - People who live close enough to the trial site to attend follow-up appointments Who may not be able to join: - People who have a moderate or severe problem with one or more heart valves (either narrowing or leaking) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT05325034 · Stephen Nicholls Not Applicable · 9 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇦🇺 AU🇨🇳 CN🇮🇳 IN🇯🇵 JP🇲🇾 MY🇸🇬 SG🇰🇷 KR🇹🇼 TW +1 more

Who might be able to join this trial: - People who are 18 years of age or older - People who have been admitted to hospital for a specific type of heart attack (called a Type I myocardial infarction) Who may not be able to join: - People whose LDL cholesterol level (a type of "bad" cholesterol measured by a blood test...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT05366153 · Baker Heart and Diabetes Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇦🇺 AU

Who might be able to join this trial: - People who had cancer more than 5 years ago and received chemotherapy and/or radiation treatment that may have affected the heart (this mainly includes survivors of breast cancer, Hodgkin's lymphoma, and prostate cancer) Who may not be able to join: - People who are unable to gi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT05636176 · Novo Nordisk A/S Phase 3 · 46 countries Recruiting
Recruiting Phase 3 Est. completion 2 July 2027
🇦🇷 AR🇦🇺 AU🇦🇹 AT🇧🇪 BE Bosnia and Herzegovina🇧🇷 BR🇧🇬 BG🇨🇦 CA +38 more

**Who might be able to join this trial:** - People who have a blood marker of inflammation called hs-CRP at a level of 2 mg/L or higher, measured at the first screening visit. - People who meet at least one of the following heart-related blood marker conditions: a heart stress marker called NT-proBNP at 300 pg/mL or h...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06056297 · X4 Pharmaceuticals Phase 3 · 25 countries Recruiting
Recruiting Phase 3 Est. completion 1 September 2027
🇦🇷 AR🇦🇺 AU🇧🇪 BE🇨🇦 CA🇨🇴 CO🇨🇿 CZ🇫🇷 FR🇬🇪 GE +17 more

**Who might be able to join this trial:** - People who have been diagnosed with a long-term low white blood cell condition (called chronic neutropenia) that is congenital (present from birth) or has developed over time due to an autoimmune or unknown cause, and where the condition has been present for at least 6 month...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06118281 · Novo Nordisk A/S Phase 3 · 24 countries Recruiting
Recruiting Phase 3 Est. completion 14 December 2026
🇦🇷 AR🇦🇺 AU🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇳 CN🇨🇿 CZ🇩🇰 DK +16 more

**Who might be able to join this trial:** - You are 18 years old or older - You have been admitted to hospital with a heart attack confirmed by a procedure that looked inside your arteries (a type of X-ray of the heart's blood vessels) - You had a specific type of heart attack (called STEMI) where symptoms started wit...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06164730 · Verve Therapeutics, Inc. Phase 1 · 6 countries Recruiting
Recruiting Phase 1 Est. completion 1 August 2026
🇦🇺 AU🇨🇦 CA🇮🇱 IL🇳🇿 NZ🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with heterozygous familial hypercholesterolemia (an inherited condition that causes high cholesterol) or with early-onset coronary artery disease (heart disease that developed at a younger age than typical) **Who may not be able to join:** - Pe...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06700720 · Beijing Inno Medicine Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2026
🇦🇺 AU

Who might be able to join this trial: - People who fully understand the study's purpose and methods, and are willing to sign a consent form before any assessments begin. - Australian patients aged between 18 and 75 years (male or female). - People who have been diagnosed with coronary artery disease (fatty buildup in t...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06813339 · Cyclarity Therapeutics, Inc. Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 30 December 2026
🇦🇺 AU

Who might be able to join this trial: **For all participants:** - The person is able to understand what the study involves and agrees to take part in writing. - The person is able to follow the study schedule and complete all required assessments. **For healthy participants (certain parts of the trial):** - Adults (m...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
🇦🇺 NCT06959524 · Boston Scientific Corporation Not Applicable · 9 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇦🇺 AU🇨🇳 CN🇩🇪 DE🇮🇪 IE🇯🇵 JP🇳🇿 NZ🇰🇷 KR🇪🇸 ES +1 more

**Who might be able to join this trial:** - People who are at least 18 years old. - People (or their legal guardian) who understand what the trial involves and have given written consent before any trial procedures begin. - People whose heart condition makes them suitable for a procedure called percutaneous coronary i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT07136012 · Amgen Phase 3 · 3 countries Recruiting
Recruiting Phase 3 Est. completion 20 October 2031
🇦🇺 AU🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - People aged 50 years or older - People whose Lp(a) (a type of cholesterol-like particle in the blood) was measured at 200 nmol/L or higher during the screening process - People who have multiple risk factors for heart and blood vessel disease, and/or signs that fatty deposits hav...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07293260 · Amgen Phase 3 · 11 countries Recruiting
Recruiting Phase 3 Est. completion 15 June 2028
🇦🇺 AU🇨🇦 CA🇨🇳 CN🇩🇰 DK🇫🇷 FR🇩🇪 DE🇮🇹 IT🇯🇵 JP +3 more

**Who might be able to join this trial:** - People aged between 35 and 80 years old - People whose Lp(a) level (a type of cholesterol-related protein in the blood) was measured at 200 nmol/L or higher during the screening process - People whose heart scan (a specialised CT scan of the heart's arteries) shows a blockage...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT00181259 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

Who might be able to join this trial: - People who are older than 18 years of age - Healthy volunteers: people with no history of heart disease - People with dilated cardiomyopathy: a history of heart failure and a weakened heart that pumps less than 40% of its blood with each beat - People with left ventricular hypert...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01186133 · Seung-Jung Park Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇰🇷 KR

Who might be able to join this trial: - People who have coronary (heart) artery disease that can be treated with a procedure called PCI, where a small tube (stent) is used to open blocked arteries - People without specific medical or heart condition limitations that would prevent participation (confirm with trial site)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01258231 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2030
🇺🇸 US

Who might be able to join this trial: - You are scheduled to have heart surgery - You are willing to give your consent to take part in the trial Who may not be able to join: - You are already taking part in another clinical trial for a drug or medical device that does not allow you to join other trials at the same tim...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01311323 · American Heart of Poland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇵🇱 PL

Who might be able to join this trial: - Adults aged 18 years or older - People who have given written consent to participate - People diagnosed with a type of heart attack or severe chest pain (called Acute Coronary Syndrome without ST-segment elevation, including NSTEMI or unstable angina) that requires urgent investi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01429727 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇺🇸 US

**Who might be able to join this trial:** - People who have been treated at Mayo Clinic and have been diagnosed with a spontaneous coronary artery dissection (SCAD) — a type of tear in a heart artery - Women who were pregnant or had given birth within the past 12 months at the time of their SCAD event - People who ide...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01566175 · Tel-Aviv Sourasky Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇮🇱 IL

Who might be able to join this trial: - You must be older than 18 years old - You must have heart disease that causes frequent chest pain (angina) that is severe — rated as Class 3 or 4, meaning it happens with minimal activity or even at rest — and has not improved after at least 30 days of the best available medicati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01757730 · Arunark Kolipaka Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older who are safe to have an MRI scan Who may not be able to join: - People who have any metal in their body that has not been approved as MRI-safe - People who are pregnant or who may possibly become pregnant - People who experience claustrophobia (fear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01788592 · Seung-Jung Park Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2030
🇰🇷 KR

Who might be able to join this trial: - People who have coronary artery (heart) disease that can be treated with a procedure called PCI, where a small tube (stent) is placed in a blocked artery to open it up - People who do not have any specific medical or heart condition factors that would prevent them from participat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01932411 · University of California, Davis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

Who might be able to join this trial: - People who were 18 years of age or older at the time of their surgery - People who had cardiovascular (heart or blood vessel) surgery at UC Davis Medical Center between January 1, 2001 and July 15, 2013 - People whose surgery was performed either with or without the use of a hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02009345 · McGill University Health Centre/Research Institute of the McGill Unive... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇨🇦 CA

Who might be able to join this trial: - People who have been clinically diagnosed with Familial Hypercholesterolaemia (FH), a condition that causes very high cholesterol and runs in families - People with a personal or family history of high cholesterol levels - People with a personal or family history of heart disease...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02038127 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇰🇷 KR

**Who might be able to join this trial:** - You are older than 19 years of age - You are able to talk through and understand the risks, benefits, and other treatment options, and you (or your legal representative) are willing to sign a consent form before any study procedures begin - You have a significant blockage (mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02355457 · Universitätsklinikum Hamburg-Eppendorf Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇩🇪 DE

Who might be able to join this trial: - People who have symptoms that suggest they may be having a heart attack - People who are able to give written consent to take part, following standard research guidelines and local laws - People who are at least 18 years old Who may not be able to join: - People who do not have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02381301 · Maastricht University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2029
🇳🇱 NL

Who might be able to join this trial: - You have been referred by a heart specialist (cardiologist) for a routine CT scan of the heart's arteries (called a CCTA). Who may not be able to join: - You are pregnant or may be pregnant - You have severe kidney problems - You have had a serious allergic reaction to the contr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02432092 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with cardiomyopathy (a condition affecting the heart muscle) - Family members of someone who has been diagnosed with cardiomyopathy Who may not be able to join: - People who have not been diagnosed with cardiomyopathy - Family members of people who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02448485 · Medical University Innsbruck Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇦🇹 AT

Who might be able to join this trial: - People who have been diagnosed with a narrowing of the aortic valve (a condition called aortic stenosis), confirmed by an ultrasound of the heart or through an invasive heart procedure. Who may not be able to join: - People who are currently experiencing an acute coronary syndro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02693509 · American Heart Association Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2040
🇺🇸 US

Who might be able to join this trial: - People who are currently in hospital being treated for congestive heart failure (a condition where the heart does not pump blood as well as it should). Who may not be able to join: - People who do not have congestive heart failure. - People who are under 18 years of age. - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02744677 · Edwards Lifesciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who weigh at least 20 kg (44 lbs) - People who have a failing or poorly functioning conduit or previously implanted valve in the pulmonary (right side of the heart) position that needs treatment, and whose anatomy falls within the size range required by the device - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02762162 · Action, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇫🇷 FR

Who might be able to join this trial: - People who have coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked) - People who have already had antiplatelet medication testing done as part of their regular medical care, and/or have had genetic testing related to how their b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02778724 · Club Régional des Angioplasticiens de la région Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇫🇷 FR

Who might be able to join this trial: - Adults aged 18 years or older at the time of enrollment - People who have previously had a coronary angiogram (a procedure that takes X-ray images of the heart's blood vessels) or an angioplasty (a procedure to open blocked or narrowed blood vessels in the heart) Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02798276 · Antoni Bayés Genís Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇪🇸 ES

Who might be able to join this trial: - People who are over 18 years old and able to give their own consent to participate - People who have a specific pattern called a "Q wave" showing on their heart tracing (ECG) - People who have had a heart attack that has affected at least 50% of the thickness of a section of hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02820233 · Douglas B. Sawyer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇺🇸 US

Who might be able to join this trial: - People who have been clinically diagnosed with severe coronary artery disease and are scheduled to have coronary artery bypass surgery (a heart operation to improve blood flow). Who may not be able to join: - People who are under 18 years of age. - People who are unwilling or un...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02845531 · Kee-joon Choi Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2030
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have survived a cardiac arrest that was successfully treated, where the cause was a documented dangerous heart rhythm (ventricular fibrillation or a very fast ventricular heartbeat) - People who have been diagnosed with variant angi...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT02998788 · Ruijin Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 or older - People who are currently admitted to hospital with one of the following conditions: heart failure causing fluid build-up in the lungs or legs, a state where the heart is too weak to pump enough blood to the body (cardiogenic shock), or a condition where...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03008291 · Yong-Mei Cha Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** **Heart Failure Group:** - People who have been medically recommended to receive a pacemaker, cardiac resynchronization device (a device that helps the heart beat in a more coordinated way), or a similar heart device, including a newer type called His-bundle or left bundle bra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03103932 · Ottawa Heart Institute Research Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who have been admitted to hospital with a main diagnosis of acute decompensated heart failure (a sudden worsening of heart failure symptoms), confirmed using a standard set of medical criteria called the modified Framingham criteria **Who may not be able to join:** -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03142659 · Tel-Aviv Sourasky Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇮🇱 IL

Who might be able to join this trial: - You must be 18 years old or older. - You must be a patient who has been seen or assessed at the Heart Failure unit or clinic at the facility running this trial. - You must have given your agreement to take part by signing a consent form. Who may not be able to join: - You may no...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03197350 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇧🇪 BE

**Who might be able to join this trial:** - People who have been diagnosed with heart failure and experience typical symptoms and signs of the condition, with a functional severity rating of Class II or above (meaning symptoms appear during ordinary activity or less) - People whose heart failure blood marker (NT-proBN...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03378739 · Inova Health Care Services Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2099
🇺🇸 US

Who might be able to join this trial: - You are a patient at the IHVI (Inova Heart and Vascular Institute) who has been treated by the Cardiogenic Shock team for either a sudden, severe worsening of heart failure or a heart attack that caused your heart to stop pumping blood effectively. Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03398369 · University of Virginia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 January 2025
🇺🇸 US

Who might be able to join this trial: - People who have long-term heart failure where the heart's main pumping chamber is not squeezing properly (known as systolic heart failure) - People whose heart's pumping strength (called ejection fraction) is 35% or lower - People whose doctors have recommended a specific heart d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03412435 · Seung-Jung Park Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇰🇷 KR

Who might be able to join this trial: - People who have been diagnosed with a heart attack, confirmed through a procedure that takes X-ray images of the heart's blood vessels (called a coronary angiogram) Who may not be able to join: - No specific exclusion criteria were listed in the official trial information (confi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03427996 · Seung-Jung Park Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇰🇷 KR

Who might be able to join this trial: - People who are 19 years of age or older - People who have received a procedure called rotational atherectomy (a procedure used to treat blocked arteries) - People who, or whose legal guardian, have agreed to the study procedures and follow-up schedule and have signed a written co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03497637 · Helios Health Institute GmbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇩🇪 DE

Who might be able to join this trial: - People who are older than 18 years of age - People who are willing to take part and are able to understand, read, and sign a consent form before any procedure takes place - People for whom a doctor has determined coronary angiography (an X-ray of the heart's arteries) and/or a pr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03588481 · Seung-Jung Park Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇰🇷 KR

Who might be able to join this trial: - People aged 19 years or older - People who are having a DeSyne X2 drug-eluting coronary stent procedure - People who have agreed to and signed a written informed consent form Who may not be able to join: - People who are having a DeSyne X2 drug-eluting coronary stent and another...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03713866 · John Sapp Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who have had one or more episodes of a specific type of sustained abnormal heart rhythm called monomorphic ventricular tachycardia (VT) - People who have been referred for a heart procedure called catheter ablation (a procedure to correct abnormal heart rhythms) - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03753412 · Barts & The London NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 September 2026
🇬🇧 GB

"Who might be able to join this trial: - People who are 18 years of age or older. - Adults experiencing severe heart and breathing failure that requires a life support machine called ECMO (a machine that pumps and oxygenates blood outside the body). - Adults for whom both a personal representative (such as a family mem...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03772275 · Sherief Abd-Elsalam Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇪🇬 EG

"Who might be able to join this trial: - People with heart failure symptoms that fall into Class II, III, or IV on a standard medical scale — meaning those who experience symptoms ranging from slight limitations during physical activity up to severe limitations even at rest (confirm with trial site) Who may not be abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03788512 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2023
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel) or a transient ischemic attack (TIA, sometimes called a "mini-stroke"). - People whose stroke or TIA symptoms started less than 30 days ago. - People who have been found to hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03789916 · Campus Bio-Medico University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2021
🇮🇹 IT

Who might be able to join this trial: - People who are having coronary artery bypass graft (CABG) surgery, with or without a heart-lung bypass machine, and with or without other heart procedures such as valve replacement. - People whose heart surgery will not fully restore blood flow to all areas of the heart, based on...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03806972 · University of Monastir Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
Tunisia

Who might be able to join this trial: - People who are admitted to the Emergency Department (ED) in Monastir, where their main diagnosis upon discharge is recorded as heart failure (HF). Who may not be able to join: - Women who are pregnant or currently breastfeeding. - People who are not fully alert or conscious, spe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03823547 · J.M. ten Berg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2050
🇳🇱 NL

**Who might be able to join this trial:** - People who have been diagnosed with Acute Coronary Syndrome (ACS) — a term that covers serious heart conditions such as a heart attack or unstable chest pain caused by reduced blood flow to the heart - People who are 18 years of age or older **Who may not be able to join:**...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03836482 · SeaStar Medical Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇺🇸 US

Who might be able to join this trial: - People aged 18 years or older - People who have blood test results showing signs of inflammation in the body (specific markers include CRP, IL-6, or a white blood cell ratio — the trial site can confirm what these mean for a specific case) - People who are currently hospitalised...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03858777 · Nabeel Hamzeh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2027
🇺🇸 US

**Who might be able to join this trial:** This trial has four different groups. You may qualify for one of them: **Group 1 – Sarcoidosis patients without heart inflammation:** - You have been diagnosed with sarcoidosis according to recognised medical guidelines (ATS/ERS criteria) (confirm with trial site) - You have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03951311 · Ruijin Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are 14 years of age or older - People who have typical heart failure symptoms as measured by a standard medical checklist called the Framingham criteria - People whose heart pumps less efficiently than normal (specifically, where the heart's pumping function is bel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03951467 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 December 2027
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 years or older - People who have been hospitalised for at least a second acute episode of heart failure (either involving the upper or lower blood pressure reading) - People who were living at home before being hospitalised for this episode - People who are cov...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03955731 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 February 2025
🇧🇪 BE

**Who might be able to join this trial:** - People who are having a type of heart attack called a STEMI (where a specific pattern is seen on a heart tracing), with symptoms that started less than 24 hours ago or that are still ongoing. - People who have read and signed a consent form agreeing to take part. **Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03999138 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇦 CA

**Who might be able to join this trial:** - You are 18 years of age or older and are willing and able to give your consent to participate - You are being treated for acute heart failure, whether your heart pumps with reduced or normal strength - You are receiving treatment for fluid build-up in the lungs (pulmonary ede...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04000061 · University Hospital, Basel, Switzerland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇭 CH

Who might be able to join this trial: - People who are admitted to hospital with a main diagnosis of Acute Coronary Syndrome (ACS), which is a condition where blood flow to the heart is suddenly reduced or blocked, such as a heart attack - People who are admitted to hospital where Acute Heart Failure (AHF) — a sudden w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04020263 · Pr Bruno LEVY Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 3 February 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older who are experiencing cardiogenic shock (a serious condition where the heart cannot pump enough blood to meet the body's needs) - People whose blood volume levels are considered adequate by their medical team - People who have been receiving a medicati...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04046237 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who have been admitted to hospital for a heart attack and are already enrolled in the Frenchie registry - People who score 5 or higher on a screening questionnaire used to check for gum disease - People who have at least six teeth, not counting wisdom teeth - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04071015 · Biobeat Technologies Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇮🇱 IL

Who might be able to join this trial: - Adults aged 18 and over, of any sex, who are admitted to the intensive care unit directly after heart surgery and require blood pressure monitoring through an arterial line (a thin tube placed in the wrist or groin artery) or a Swan-Ganz catheter (a tube placed in the heart to mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04088682 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2035
🇨🇳 CN

**Who might be able to join this trial:** - People who have had a type of heart attack called a STEMI and arrive at the hospital within 48 hours of their symptoms starting. **Who may not be able to join:** - No specific exclusion criteria have been listed for this trial (confirm with trial site). **Important: Always...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04113356 · Medical University Innsbruck Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇦🇹 AT

Who might be able to join this trial: - People who have had their first-ever heart attack of a specific type (called an ST-elevation myocardial infarction, or STEMI), diagnosed using standard international medical guidelines - People who received an emergency procedure to open a blocked heart artery (called a primary P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04158479 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇨🇳 CN

"Who might be able to join this trial: - People who are currently receiving ECMO (a machine that supports the heart and/or lungs by pumping and oxygenating blood outside the body) Who may not be able to join: - People who do not give their consent to participate in the trial Important: Always verify eligibility with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04185285 · University of Freiburg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2017
🇨🇭 CH

Who might be able to join this trial: - People who have had a procedure to open blocked heart arteries (called a percutaneous coronary intervention, or PCI) at the trial institution - People who are willing to take part and are able to give their formal agreement to participate Who may not be able to join: - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04196712 · University Hospital, Essen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇩🇪 DE

Who might be able to join this trial: - You are having a procedure done to look at the blood vessels of your heart (called a coronary angiography) at the West German Heart and Vascular Center. Who may not be able to join: - There are no stated reasons that would stop someone from joining this trial. Important: Always...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04201015 · University of Leeds Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2024
🇬🇧 GB

Who might be able to join this trial: - People who have heart failure that has been confirmed through clinical assessment, heart ultrasound (echocardiogram), and hormone-level testing - People who have a cardiac pacemaker fitted - People who are physically able to complete a peak exercise test (an exercise test that me...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04237701 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2030
🇺🇸 US

Who might be able to join this trial: - You receive your healthcare within the Yale New Haven Health System - You have been diagnosed with heart failure Who may not be able to join: - You are under 18 years of age Important: Always verify eligibility with the trial site directly before applying.

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04240834 · Fu Wai Hospital, Beijing, China Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have had a serious heart event (called acute coronary syndrome) and are considered at high risk of future heart problems, and who have had a successful procedure to open blocked arteries (PCI) with at least one drug-coated stent placed - People who are willing and...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04295252 · Niguarda Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇮🇹 IT

Who might be able to join this trial: - People who are admitted to hospital with a serious heart condition called cardiogenic shock (where the heart cannot pump enough blood to meet the body's needs) at one of the participating hospitals, between January 2020 and December 2030. - People whose blood pressure is dangerou...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04330651 · University of Florence Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 March 2021
🇮🇹 IT

Who might be able to join this trial: - People who have undergone cardiac (heart) surgery Who may not be able to join: - People under 18 years of age Important: Always verify eligibility with the trial site directly before applying.

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04332692 · Central Hospital, Nancy, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 August 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who have been admitted to hospital with acute (sudden or severe) heart failure - People whose doctor considers them ready to be discharged from hospital after being treated for acute heart failure - People aged 18 or older - People who have been fully informed about ho...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04343430 · Central Hospital, Nancy, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 August 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who have been admitted to hospital with acute (sudden or severe) heart failure - People whose heart is pumping with a normal or near-normal squeezing strength (called "preserved ejection fraction," meaning the heart pumps out at least 50% of its blood with each beat) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04343443 · Central Hospital, Nancy, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 August 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who are currently in hospital being treated for sudden (acute) worsening heart failure - People whose heart is not pumping as strongly as it should be (the heart's pumping strength is measured as less than 50%) - People who are considered medically ready to be discharg...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04347434 · Penza State University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 12 November 2027
🇷🇺 RU

**Who might be able to join this trial:** - People who have signed a consent form agreeing to take part in the study. - People who have been diagnosed with a heart attack (either a STEMI or NSTEMI type), confirmed through heart tracing tests (ECG), blood tests (troponin I and CPK-MB), and a procedure that takes images...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04396899 · University Medical Center Goettingen Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
🇩🇪 DE

**Who might be able to join this trial:** - You have heart failure with symptoms (such as shortness of breath or fatigue) and your heart's pumping strength is significantly reduced, confirmed by an ultrasound of the heart - You are already taking the standard recommended medications for heart failure - A blood test sh...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04405583 · Occlutech International AB Not Applicable · 8 countries Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇫🇷 FR🇩🇪 DE🇬🇷 GR🇮🇹 IT🇵🇹 PT🇷🇸 RS Tunisia Turkey (Türkiye)

**Who might be able to join this trial:** - People aged 18 or older who have given written consent to participate - People living with long-term heart failure that causes symptoms, rated at a certain level of severity (NYHA Class 2 or above) - People whose left side of the heart shows higher pressure than the right si...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04416581 · Duk-Woo Park, MD Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇰🇷 KR

**Who might be able to join this trial:** - People aged 19 or older who have a known heart or blood vessel condition and are currently taking long-term blood-thinning medicines (such as blood clot prevention tablets or blood thinners taken by mouth). Qualifying conditions may include coronary artery disease, a history...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04419480 · Inova Health Care Services Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** - The patient (or their legal representative) has signed a consent form, and the investigator considers the patient able to participate and complete study questionnaires. - Adults aged 18 years or older. - People diagnosed with a moderate-to-severe level of heart failure (call...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04441203 · Montreal Heart Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇦 CA

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender - People with heart failure who have had at least one hospital admission for heart failure in the past 12 months, with moderate symptoms (confirm with trial site for exact symptom classification) - People with heart failure who have had...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04448639 · Vastra Gotaland Region Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2024
🇸🇪 SE

Who might be able to join this trial: - People who have had a specific type of heart attack (called a STEMI or Takotsubo syndrome) and are scheduled to have a procedure to look at the heart's blood vessels within 12 hours of symptoms starting - People who are able to give written agreement to take part in the trial Wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04458883 · University of Aberdeen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
🇬🇧 GB

**Who might be able to join this trial:** - People who are willing and able to give their agreement to take part in the study - Healthy volunteers who are willing to give their agreement to take part in the study - People who have previously been diagnosed with a heart attack **Who may not be able to join:** - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04465591 · University of Turku Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 30 December 2028
🇫🇮 FI🇨🇭 CH

"Who might be able to join this trial: - A blood sample containing a substance called Troponin T (a protein related to heart function) must have been collected from the patient being considered for the trial. Who may not be able to join: - People under 18 years of age are not eligible. Important: Always verify eligib...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04471129 · University Hospital, Rouen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 September 2026
🇫🇷 FR

**Who might be able to join this trial:** - You must be an adult (18 years or older) - You must have had heart surgery using a heart-lung bypass machine more than 24 hours ago, and have had your breathing tube removed for at least 6 hours - You must have had a weak heart (with the heart pumping less than 40% of its cap...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04496947 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

Who might be able to join this trial: - People aged between 30 and 65 years old - People who feel they have higher than normal levels of stress, or who score above 5 on a standard stress measurement questionnaire (called the Perceived Stress Scale), and who want to take part Who may not be able to join: - People who s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04505865 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who report feeling stressed, or who score above 13 on a standard stress measurement scale (indicating moderate stress) - People who are willing to complete a stress reduction course and attend imaging sessions, with fewer than 3 missed appointments in the past year -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04521699 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People aged 18 years or older - People who are able to use the CamliGo device for 12 weeks - People who are willing to complete study questionnaires, blood tests, and EndoPat testing (a test of blood vessel function) at the start and end of the study - People who have recently ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04576130 · Rigshospitalet, Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2032
🇩🇰 DK

Who might be able to join this trial: - People who have coronary artery disease (narrowed heart arteries) and experienced a cardiac arrest caused by a dangerous abnormal heart rhythm, and who had a procedure to open or bypass the blocked arteries before having a defibrillator device (ICD) implanted. - People aged 18 or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04583800 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇫🇷 FR

"Who might be able to join this trial: - You must be an adult (18 years or older). - You must be able to understand the information given about the trial and be able to agree or disagree to take part. - You must have been diagnosed with type 2 diabetes and must NOT have heart failure at stage B or above. - You must be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04592445 · Axon Therapies, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 January 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have chronic heart failure and have been taking water pills (diuretics) — either regularly or occasionally — for more than 30 days to manage their symptoms. - People whose heart failure symptoms fall into a moderate-to-severe category (known as NYHA Class II with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04603404 · Chinese Academy of Medical Sciences, Fuwai Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People whose heart is pumping out blood at a normal or near-normal rate (a measure called ejection fraction of 50% or above) - People with elevated levels of certain proteins in the blood (NT-proBNP or BNP) that indicate the heart is under stress - People who have symptoms an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04604782 · GE Healthcare Phase 2 · 4 countries Recruiting
Recruiting Phase 2 Est. completion 1 December 2026
🇫🇷 FR🇬🇷 GR🇮🇹 IT🇬🇧 GB

**Who might be able to join this trial:** - The patient is an adolescent aged 12 to under 18 years (Cohort A), a child aged 2 to under 12 years (Cohort B), or an infant aged 1 to under 24 months (Cohort C) - The patient weighs at least 3 kg - The patient has been assessed by the investigator as needing, and being medi...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04606459 · Johannes Gutenberg University Mainz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 October 2025
🇩🇪 DE

**Who might be able to join this trial:** - People aged between 18 and 85 years old - People who have a long-term heart condition causing chest pain or similar symptoms (called chronic coronary syndrome) that remains severe (classified as CCS class III or IV) despite already receiving the recommended medications - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04654988 · Medical University of Warsaw Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2027
🇵🇱 PL

**Who might be able to join this trial:** - People who have given written consent to take part in the study, including agreeing to two heart tissue biopsies and two heart MRI scans. - People who have been clinically suspected of having, or already diagnosed with, myocarditis (inflammation of the heart muscle) or infla...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04662970 · Medical University Innsbruck Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇦🇹 AT

Who might be able to join this trial: - People who have recently had a specific type of heart device (called a CRT-D or CRT-P) successfully implanted, where the device includes a special programming feature called SyncAV® - People whose heart device is compatible with a cardiac MRI scan (a detailed imaging scan of the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04728516 · Qilu Hospital of Shandong University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with a type of heart attack (called ACS) and had a procedure to open blocked arteries (called PCI/stenting), and have been taking two blood-thinning medications together for at least 6 months afterward - You have tested positive for a stomach bacteria...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04741711 · Central Hospital, Nancy, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years of age or older (male or female) - You have been diagnosed with heart failure (any type) - Your heart failure diagnosis was made more than 3 months ago - You do not currently have significant signs of fluid build-up in your body, such as crackling sounds in t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04768322 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2029
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People with end-stage heart failure, as assessed by a local heart specialist team, where the heart's pumping ability (measured by a scan) is at or below 35%, confirmed within one week before joining the trial - People whose heart is not pumping enou...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04769362 · Samsung Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 January 2026
🇰🇷 KR

Who might be able to join this trial: - People who are at least 19 years of age. - People who have been taking beta-blocker medication continuously for at least 1 year following a heart attack, regardless of when the heart attack was diagnosed. - People who are able to verbally confirm they understand the risks and ben...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04772768 · Amsterdam UMC, location VUmc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 July 2024
🇳🇱 NL

Who might be able to join this trial: - People who have previously had coronary artery bypass graft (heart bypass) surgery - People who had one or more vein grafts taken from the leg used during that bypass surgery - People who are experiencing chest pain or discomfort (angina) that has come back after their bypass sur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04779008 · Henan Institute of Cardiovascular Epidemiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have three blocked heart arteries and have been scheduled for coronary artery bypass graft (CABG) heart surgery **Who may not be able to join:** - People whose bodies cannot tolerate the remote ischemic preconditioning (RIPC) procedure used in this trial (confirm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04814212 · North Karelia Central Hospital Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇫🇮 FI🇫🇷 FR🇩🇪 DE🇬🇧 GB

**Who might be able to join this trial:** - Adults aged 18 or older who are able to provide written consent to participate - People who meet at least one "major" or two "minor" bleeding risk factors, as defined by an international research standard called the Academic Research Consortium (ARC) **Major bleeding risk f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04815928 · Amsterdam UMC, location VUmc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2035
🇳🇱 NL

Who might be able to join this trial: - Adults aged 18 years or older. - People who have already had, or are scheduled to have, a medically necessary procedure to take detailed pictures of the heart's arteries (called a coronary angiography). - People who have already had, or are scheduled to have, a medically necessar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04829617 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

Who might be able to join this trial: - Adults who have been diagnosed with heart failure classified as mild to moderate in severity (known as NYHA Class I, II, or III). - People whose adherence to recommended health behaviours — such as following a healthy diet, exercising, and taking medications as directed — has bee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04873687 · Universitas Padjadjaran Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇮🇩 ID

Who might be able to join this trial: - You are 18 years old or older - You have been diagnosed with stable angina pectoris (chest pain or discomfort caused by reduced blood flow to the heart that occurs in a predictable pattern) - You have blockages in 2 or 3 coronary arteries (the blood vessels that supply your heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04905160 · Aventyn, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 February 2025
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older (both men and women) - People who are currently in hospital with a main diagnosis of acute worsening heart failure or a heart attack - People whose heart failure has been confirmed through symptoms, physical signs, fluid build-up in the lungs, abnormal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04906356 · Cardiology Research UBC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2033
🇨🇦 CA

"Who might be able to join this trial: - People who have been admitted to hospital with a type of heart attack or severe chest pain condition (known as ACS — this includes STEMI, NSTEMI, or unstable angina). - People who have a confirmed diagnosis of a specific type of artery tear called SCAD (spontaneous coronary arte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04927429 · National Heart, Lung, and Blood Institute (NHLBI) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇺🇸 US

**Who might be able to join this trial:** **Group A (people with a medical reason for a heart MRI):** - People aged 18 or older, of any gender, who are willing and able to sign a consent form and take part for the full length of the study - People who are already scheduled for a medically necessary heart MRI — for exa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04970888 · Montreal Heart Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People aged 50 years or older - People who have been diagnosed with chronic heart failure and whose condition has been stable for at least 2 months, with heart medications adjusted to the highest tolerated dose during that time - People whose heart failure symptoms range from...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05015660 · McGill University Health Centre/Research Institute of the McGill Unive... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who are 18 years of age or older - People whose heart is pumping at more than 35% of its normal capacity (a measure called ejection fraction) - People who need a heart pacemaker due to a significant electrical conduction problem between the upper and lower chambers of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05023785 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who were diagnosed with cancer at age 39 or younger, and who are between 18 and 45 years old at the time of joining the trial - People who received cancer treatments known to carry risks to the heart, such as certain chemotherapy drugs (for example, anthracyclines, tr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05027984 · Centro per la Lotta Contro l'Infarto - Fondazione Onlus Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇬🇷 GR🇮🇹 IT🇪🇸 ES🇨🇭 CH

**Who might be able to join this trial:** - You are 18 years of age or older. - You have been diagnosed with acute coronary syndrome (a condition including heart attacks or serious chest pain caused by reduced blood flow to the heart). - You have one or more coronary artery blockages that are considered "intermediate"...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05028777 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2026
🇨🇭 CH

Who might be able to join this trial: - People who were at least 18 years old at the time of enrolment - People who had a blood clot in the left ventricle (a chamber of the heart) identified by an echocardiogram, MRI, or CT scan between January 1st, 2013 and July 31st, 2020 - People who received treatment at least once...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05057806 · The University of Texas Health Science Center at San Antonio Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 30 November 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with Type 2 Diabetes - People who have been diagnosed with heart failure with a reduced pumping function (the heart pumps out less than 50% of the blood it holds), rated as Class II or III severity by their doctor - People aged between 18 and 8...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT05068674 · Joseph C. Wu Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - People aged 21 or older but under 80 years of age. - People who are willing and able to provide written consent to participate. - People who have been diagnosed with long-term heart muscle weakness caused by a previous heart attack, confirmed by an imaging study showing bloc...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05073419 · Samir Saba Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - You are 18 years of age or older - You have had a heart attack (either a STEMI or NSTEMI type) - You are willing to sign a consent form agreeing to take part in the study - You are expected to be discharged from hospital within 7 days of your heart attack - You are willing to hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05075317 · University of Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇦 CA

Who might be able to join this trial: - People who have been referred to an outpatient cardiac rehabilitation program for coronary artery disease or peripheral vascular disease, and who meet the program's eligibility requirements - People who are willing to be randomly assigned to a study group and complete all study a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05097898 · Central Hospital, Nancy, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 December 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who have been diagnosed with chronic heart failure where the heart's pumping function is still within normal range (a measurement of 50% or higher) - People who are admitted to hospital for a planned day visit or outpatient consultation related to their heart condition...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05100992 · Minneapolis Heart Institute Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇺🇸 US

"Who might be able to join this trial: - People who are over 18 years of age - People who are having a procedure to open a blocked or narrowed artery at a point where the artery splits into two branches (a procedure known as bifurcation percutaneous coronary intervention) Who may not be able to join: - No exclusion cr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05138575 · University of Pennsylvania Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 May 2027
🇺🇸 US

Who might be able to join this trial: - People who have moderate heart failure symptoms that limit activity somewhat, but who are still able to do some physical activity (known as NYHA Class II or III). - People whose heart is pumping with at least 50% of its normal pumping strength (measured by an echocardiogram). - P...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05140434 · Centre Hospitalier Sud Francilien Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇫🇷 FR

Who might be able to join this trial: - People who began the relevant assessment or treatment period between January 1, 2019 and March 1, 2022 - People aged 18 years or older - People who had both an exercise test and either a cardiac CT scan or a coronary angiography performed within 3 months of each other - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05152888 · Brigham and Women's Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - Men aged 50 or older, or women aged 55 or older - People with an LDL ("bad") cholesterol level of 70 mg/dL or higher - People with stable coronary artery disease (meaning no surgery to open blocked arteries is planned before the study begins), confirmed by one or more of the...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05168462 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 April 2027
🇳🇱 NL

Who might be able to join this trial: - People who have had a heart attack (either a STEMI or NSTEMI type) - People who have had a procedure to reopen the blocked heart artery (called PCI) done early after their heart attack - People whose blood pressure has dropped very low (90 mmHg or below) for more than 30 minutes,...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05174351 · UConn Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged between 50 and 80 years old - People who have been diagnosed with a stable form of heart failure where the heart's pumping function is preserved (known as HFpEF), with symptoms classified as moderate (NYHA Class II–III) or a specific elevated blood marker related...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05204693 · University of Zurich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2025
🇨🇭 CH

**Who might be able to join this trial:** - Your condition has been stable and you have been on the same medication for it for more than 4 weeks. - You are willing and able to sign a consent form agreeing to take part. - You have been diagnosed with a left-heart disease (a condition affecting the left side of the heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05211401 · Assistance Publique - Hôpitaux de Paris Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2027
🇫🇷 FR

Who might be able to join this trial: - People aged 18 or older (women must be either postmenopausal for more than 2 years with appropriate signs such as being over 55 with a history of hot flushes, or have had a hysterectomy and/or removal of both ovaries) - People who are having a specific type of heart attack called...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05248165 · Federico II University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2032
🇮🇹 IT

Who might be able to join this trial: - People who have coronary artery disease (a condition where the heart's blood vessels are narrowed or blocked) and need a procedure called PCI (a treatment that opens up blocked heart arteries, often using a small balloon or stent) - People who are 18 years of age or older - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05250557 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇰🇷 KR

Who might be able to join this trial: - People aged 20 years or older - People who have already had a successful FFR measurement and pullback tracing performed (this is a heart artery pressure test used to check for blockages) Who may not be able to join: - People with severe chronic kidney disease (where kidney filte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05255705 · Queen Mary University of London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇬🇧 GB

**Who might be able to join this trial:** - Adults and young people aged 16 or older are included in the study. - Both male and female patients are included. - People who have had a procedure to look at the blood vessels of the heart (called an angiogram) at Blackpool Heart Centre are included. - People who have had a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05257629 · Sir Mortimer B. Davis - Jewish General Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 7 March 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who are currently in hospital, being discharged, or are outpatients who have had a recent heart attack or unstable chest pain (angina) meeting specific medical criteria, OR outpatients who have a diagnosis related to heart and blood vessel disease, kidney disease, str...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05262803 · Rikke Sorensen Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2028
🇩🇰 DK

**Who might be able to join this trial:** - People who have had a specific type of heart attack (called a Type 1 MI) caused by a blood clot blocking a coronary artery, where blood test results showed elevated heart damage markers along with at least one other sign such as chest symptoms, abnormal heart tracing (ECG),...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05267886 · Ottawa Heart Institute Research Corporation Phase 4 · 2 countries Recruiting
Recruiting Phase 4 Est. completion 1 December 2026
🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - People aged 18 or older who have been admitted to an intensive care unit - People who have been diagnosed with cardiogenic shock at a moderate or severe level (known as SCAI class C or D), meaning the heart is not pumping enough blood to meet the body's needs Who may not be able...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05272618 · Chonnam National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇰🇷 KR

**Who might be able to join this trial:** - People aged 19 years or older who have had a heart attack, confirmed by specific blood test results (called cardiac troponin) combined with symptoms of reduced blood flow to the heart - People whose heart arteries are found to be not significantly blocked — meaning less than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05292651 · Albert Schweitzer Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇳🇱 NL

**Who might be able to join this trial:** - People who have stable chest pain (angina) or have had a recent heart attack with at least one other stable, narrowed heart artery that was not the direct cause of the heart attack - People who have one or more significantly narrowed coronary arteries (the blood vessels suppl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05292716 · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 April 2025
🇮🇹 IT

**Who might be able to join this trial:** - You are between 18 and 90 years old - You have a significant leaking mitral heart valve (a specific type called "secondary mitral regurgitation"), confirmed by heart scan at the end of the screening period - You are already receiving the best available medicines for your hea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05303896 · Oslo University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇳🇴 NO

Who might be able to join this trial: - People who have been assessed as suitable candidates for a heart transplant - People who are willing to take part in the study and are able to understand and sign a written consent form Who may not be able to join: - People who are under 18 years of age Important: Always verify...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05305482 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 February 2030
🇰🇷 KR

Who might be able to join this trial: - People aged 19 years or older - People who have been assessed as suitable candidates for treatment with a drug-coated or drug-eluting stent (a small mesh tube placed in an artery) due to a condition called acute coronary syndrome (a sudden, serious heart condition such as a heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05312164 · Gentuity, LLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇺🇸 US

**Who might be able to join this trial:** - People who are older than 18 years of age - People who are willing and able to give written consent to participate - People who have symptoms or signs that suggest possible coronary artery (heart) disease - People who are being considered for a procedure to open blocked heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05327062 · XSpline S.p.A. Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇦🇹 AT🇭🇺 HU🇮🇹 IT🇳🇱 NL🇪🇸 ES🇨🇭 CH🇺🇸 US

**Who might be able to join this trial:** - People who are able to give signed and dated consent to take part in the trial - People who are 18 years of age or older at the time of giving consent - People whose heart condition meets the guidelines for a treatment called cardiac resynchronisation therapy (CRT), based on...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05330221 · Henry Ford Health System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People who live in the Detroit area (defined as those who attended a Detroit-area community event) - People who are 18 years of age or older - People whose blood pressure at screening was measured at 140/90 mmHg or higher (without blood pressure medication) - People whose bl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05332262 · University of Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People with stable coronary artery disease (a long-term narrowing of the heart's arteries) who are scheduled for a planned, non-emergency procedure to open those arteries (called PCI) - Adults aged 18 or older, of any gender - People whose troponin blood test (a marker of heart m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05339477 · Sahlgrenska University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 April 2026
🇸🇪 SE

Who might be able to join this trial: - People who have given their signed agreement to take part in the study - People who have been diagnosed with a type 1 heart attack that has been recorded in a Swedish heart disease registry called SWEDEHEART - People who were between 18 and 79 years old when they left the hospita...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05344612 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇳🇱 NL

Who might be able to join this trial: - People who are older than 18 years of age Who may not be able to join: - People who are currently experiencing a heart attack or unstable chest pain (acute coronary syndrome) - People who have had a heart attack or unstable chest pain episode within the last 3 months - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05347069 · Takeshi Morimoto Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2030
🇯🇵 JP

**Who might be able to join this trial:** - People who have been diagnosed with chronic (long-term, stable) coronary artery disease, where one or more of the major blood vessels supplying the heart has at least 50% blockage, confirmed by a CT scan or angiogram (an X-ray of the heart's arteries) - People whose doctors h...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05347732 · Oslo University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 April 2025
🇳🇴 NO

Who might be able to join this trial: - Adults older than 18 years old who have had a type of heart attack called a STEMI and were given clot-dissolving medication before arriving at the hospital. Who may not be able to join: - No exclusion criteria have been listed for this trial (confirm with trial site). Important...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05366452 · Assistance Publique Hopitaux De Marseille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇫🇷 FR

Who might be able to join this trial: - People aged between 18 and 80 years old - People who experienced an acute coronary syndrome (a serious heart event such as a heart attack) within the last 24 hours - People diagnosed with cardiogenic shock, meaning the heart is not pumping enough blood — shown by low blood pressu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05367297 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People who identify as South Asian, with both biological parents having ancestry from India, Pakistan, Sri Lanka, Nepal, or Bangladesh - Adults from other ethnic backgrounds may also be eligible to join as a comparison group Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05369442 · West China Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇨🇳 CN

**Who might be able to join this trial:** - People over 18 years old who have had a procedure to open blocked heart arteries (called PCI) AND who meet at least one "major" risk factor for serious bleeding, or at least two "minor" risk factors for bleeding, as listed below. **Major bleeding risk factors (one of these...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05373940 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2030
🇫🇷 FR

**Who might be able to join this trial:** - People who are 70 years of age or older - People whose heart pumps less efficiently than normal (the heart is pumping out 35% or less of its blood with each beat), confirmed by a heart scan done at the time of joining or within the 6 weeks before joining - People with moderat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05380622 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who have a medical reason to undergo a coronary CT angiography (a special heart scan that looks at the arteries of the heart) - People who have read and signed a written consent form agreeing to take part Who may not be able to join: - People whose heart pumps at less tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05392764 · Juntendo University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2026
🇯🇵 JP

**Who might be able to join this trial:** - People aged 20 or older (people aged 90 or older may need to complete a short memory/thinking check to confirm a minimum score) - People who have been admitted to hospital with acute heart failure and are being treated with diuretic medication given through a vein (IV), and...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05410925 · The First Affiliated Hospital with Nanjing Medical University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 75 years who weigh at least 45 kg - People who have been diagnosed with a specific type of heart attack (STEMI), where chest pain caused by reduced blood flow to the heart has lasted at least 30 minutes - People whose heart attack diagnosis is confirmed by...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05416879 · Newcastle University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇬🇧 GB

**Who might be able to join this trial:** - Adult women who have recently been diagnosed with heart failure after being seen at the RVI Heart Failure Diagnostic Clinic - People who are able to walk and carry out everyday tasks (such as dressing and cooking) on their own - People whose heart failure symptoms fall withi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05417490 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇫🇷 FR

Who might be able to join this trial: - Adults (18 years or older) may be considered for this trial. - People who are currently in hospital for heart failure, or for another condition where heart failure is playing a significant or worsening role (such as a co-infection), as recognised by their treating doctor, may be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05418556 · Asan Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 19 years or older - People experiencing typical chest pain, or who have test results showing reduced blood flow to the heart, where a procedure to open blocked arteries (called PCI) is considered appropriate - People who have new blockages in their heart arteries...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05426083 · University of Minnesota Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 75 years old - People who have a severe form of cardiogenic shock (when the heart cannot pump enough blood) that requires a specific heart-lung support machine called VA-ECMO, as determined by their treating medical team - People whose blood pressur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05434819 · Population Health Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are already scheduled to have heart surgery for a medical reason, such as bypass surgery (CABG), heart valve replacement (aortic valve), replacement of part of the main artery from the heart (ascending aorta), or a combinat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05437900 · CoreAalst BV Phase 4 · 8 countries Recruiting
Recruiting Phase 4 Est. completion 30 June 2026
🇧🇪 BE🇨🇳 CN🇫🇷 FR🇩🇪 DE🇮🇹 IT🇳🇱 NL🇵🇱 PL🇪🇸 ES

**Who might be able to join this trial:** - You are at least 18 years old and younger than 85 years old. - You are scheduled for a planned (non-emergency) heart procedure to open blocked arteries (called PCI). - You have either stable chest pain (stable angina) or a recent heart event (such as a heart attack), with spe...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05455515 · Fondazione GISE Onlus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇮🇹 IT

**Who might be able to join this trial:** - Adults aged 18 or older. - People who have hardened (calcified) blockages in their heart arteries that need to be treated with a procedure to open the artery and place a stent, specifically using a device called a Shockwave catheter. - People whose calcium deposits in the ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05459233 · Institut universitaire de cardiologie et de pneumologie de Québec, Uni... Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - People who have a failing surgically implanted heart valve (a type called a bioprosthetic valve) with severe narrowing and/or leaking of the aortic valve, where the heart team has approved a "valve-in-valve" procedure (placing a new valve inside the existing one) - People whose s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05461729 · Dr. Boris Schmitz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2029
🇩🇪 DE

**Who might be able to join this trial:** - People who have been diagnosed with coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked) and have had a heart attack and/or a procedure to open blocked heart arteries and/or heart bypass surgery, and who are currently taking...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05472337 · Pontificia Universidad Catolica de Chile Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 March 2026
🇨🇱 CL

**Who might be able to join this trial:** - Adults aged 18 or older - People who are currently admitted to the Clinical Hospital of the Catholic University with a heart condition involving chest pain and elevated blood markers of heart damage (with or without changes on a heart tracing test) - People who are scheduled...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05486000 · Morningside (Nantong) Medical Co.,Ltd Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older - People with chronic left-sided heart failure who are still experiencing symptoms despite being on stable, guideline-recommended heart failure medications for at least 1 month - People who have been hospitalised for heart failure in the past 12 month...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05491200 · Research Maatschap Cardiologen Rotterdam Zuid Phase 4 · 6 countries Recruiting
Recruiting Phase 4 Est. completion 1 August 2027
🇧🇪 BE🇨🇿 CZ🇩🇪 DE🇮🇹 IT🇳🇱 NL🇷🇸 RS

**Who might be able to join this trial:** - People who have had a heart attack (specifically a type called STEMI) and are planned to have a procedure to open a blocked artery (called PCI or stent placement) - People whose heart attack is confirmed by at least 20 minutes of chest discomfort at rest, along with specific...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05492110 · Imperial College London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 March 2026
🇬🇧 GB

**Who might be able to join this trial:** - People who are over 18 years of age - People who have had ongoing chest pain (angina) symptoms rated as moderate to severe for at least 3 months, even while taking at least two anti-anginal (chest pain) medicines at the highest doses they can tolerate - People who are willing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05500859 · University Hospital, Basel, Switzerland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2035
🇨🇭 CH

Who might be able to join this trial: - People who are taking part in an outpatient cardiac rehabilitation program (this is open to all age groups) - People who are able and willing to sign a written agreement to participate in the study Who may not be able to join: - People who are unable to continue attending the ou...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05508035 · John Paul II Hospital, Krakow Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 March 2027
🇵🇱 PL

**Who might be able to join this trial:** - People aged 18 or older. - People who have heart failure caused by reduced blood flow to the heart (ischemic origin), with symptoms classified as moderate to severe (NYHA Class II to IV). - People whose heart's pumping strength (left ventricular ejection fraction) was measur...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05520762 · Montefiore Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People who are currently admitted to hospital for any medical reason - People who have had a cardiac arrest while in hospital (meaning their heart stopped and they needed at least 2 minutes of chest compressions) - People who need help with their b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05544864 · Deutsches Herzzentrum Muenchen Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇩🇪 DE🇪🇸 ES

**Who might be able to join this trial:** - You have chest pain or other symptoms suggesting reduced blood flow to the heart, or tests have shown your heart is not getting enough blood - A previously placed drug-coated stent in one of your heart's own arteries has narrowed again by 50% or more - An imaging scan called...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05548413 · Jia-Rong Wu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

**Who might be able to join this trial:** **For patients with heart failure:** - People who have a confirmed diagnosis of heart failure (either the pumping or relaxing type) - People who have had trouble taking their heart failure medications as prescribed - People who have a care partner (such as a spouse, child, par...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05549752 · Hippocration General Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 December 2025
🇬🇷 GR

**Who might be able to join this trial:** - You are between 18 and 85 years old. - You have been diagnosed with a type of irregular heartbeat called paroxysmal atrial fibrillation, confirmed by a heart tracing (ECG), and your symptoms started less than 48 hours before arriving at the Emergency Department. - Alternativ...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05553886 · Shenzhen People's Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People diagnosed with chronic heart failure (a long-term condition where the heart does not pump blood as well as it should) that is classified as moderate to severe, where the heart's pumping function is significantly reduced, and where a specific heart-related protein in th...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05564689 · Ashkan Eftekhari Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇩🇰 DK

**Who might be able to join this trial:** - You are over 18 years old - Your heart's electrical signal takes longer than usual to travel through the heart (a measurement called QRS of 150 milliseconds or more), measured before your device was put in - Your heart failure is caused by a condition where the heart muscle i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05586282 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇫🇷 FR

**Who might be able to join this trial:** - A patient (or their legal representative, family member, or close relative) is able to provide consent for the patient to take part - The patient is covered by French social security (excluding AME) - The patient is experiencing one of the following types of circulatory fail...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05604131 · Rohan Dharmakumar Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 March 2029
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 79 years - People who have had a specific type of heart attack called an anterior wall STEMI (a blockage affecting the front wall of the heart) - People who have undergone an emergency procedure to open a blocked heart artery (known as a primary PCI...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05618353 · VA Office of Research and Development Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 July 2028
🇺🇸 US

**Who might be able to join this trial:** - People (men and women) who have previously had a procedure to open or bypass blocked heart arteries, OR who have been found on heart imaging to have significant blockages in major heart arteries. - People who are scheduled for a type of surgery considered to carry an interme...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05624905 · Samsung Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇰🇷 KR

**Who might be able to join this trial:** - People who have already had, or are planned to have, a procedure to check the blood vessels of the heart (called a coronary angiography) along with a procedure to open blocked heart arteries (called a percutaneous coronary intervention, or PCI — sometimes referred to as a ste...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05635227 · Rigshospitalet, Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇩🇰 DK

Who might be able to join this trial: - People who are 18 years of age or older - People who are scheduled for coronary artery bypass grafting (heart bypass surgery) and/or aortic valve replacement, regardless of whether other valve surgery is also being performed at the same time Who may not be able to join: - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05650307 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 September 2027
🇺🇸 US

Who might be able to join this trial: - People who are over 18 years old - People who are able and willing to provide written consent to participate - For the bariatric (weight loss) surgery group: people with obesity (a body mass index of 30 or above) or, for the control group, people without obesity (a body mass inde...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05696522 · Barts & The London NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 May 2026
🇬🇧 GB

Who might be able to join this trial: - People aged between 18 and 85 years old. - People who have had at least three episodes of a dangerous fast heart rhythm called ventricular tachycardia (VT) in the past six months, where their implanted heart device (ICD) had to deliver treatment to stop it. - People whose VT has...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05698732 · Fundación EPIC Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇫🇷 FR🇪🇸 ES

**Who might be able to join this trial:** - People who are at least 18 years old - People for whom a procedure to open blocked heart arteries (called PCI) is recommended according to current European cardiology guidelines, or for whom this procedure has already been planned as part of their regular treatment - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05699629 · Shandong First Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 January 2027
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with coronary heart disease, or who have unexplained chest pain and are scheduled to have a coronary angiography procedure (an imaging test to look at the heart's blood vessels). - Healthy people attending a routine health check-up who are willing t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05700617 · University of Chicago Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - The heart's pumping function (left ventricle) is measured at 40% or less of normal capacity. - The person has been referred for a right heart catheterisation (a procedure to measure blood pressure and flow inside the heart) for one of the following reasons: to be assessed for adv...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT05704296 · Ho Young Hwang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
🇰🇷 KR

Who might be able to join this trial: - People who are scheduled to have heart bypass surgery (coronary artery bypass grafting) - People who are older than 19 years - People whose bypass surgery will use a specific artery from the chest wall (left internal thoracic artery) and a vein taken from the leg (saphenous vein...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05714241 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇮🇹 IT🇪🇸 ES

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with INOCA (a condition where the heart does not get enough blood flow, but no blockages are found in the main heart arteries) - People who are currently taking low-dose aspirin (100 mg daily by mouth for more than 3 da...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05718128 · Second Affiliated Hospital, School of Medicine, Zhejiang University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2031
🇨🇳 CN

Who might be able to join this trial: - You are between 18 and 80 years old (any gender) and are having a heart tissue sample (biopsy) taken at the Second Affiliated Hospital of Zhejiang University School of Medicine - You have been diagnosed with, or are suspected to have, myocarditis (heart inflammation), cardiomyopa...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05719545 · Su Guohai Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with acute coronary syndrome (a sudden reduction in blood flow to the heart, such as a heart attack or unstable chest pain) and need to have a procedure called percutaneous coronary intervention (a procedure to open blocked heart arteries). - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05724433 · Population Health Research Institute Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇦 CA Tunisia

**Who might be able to join this trial:** - Adults aged 18 or older who are being discharged from hospital after being admitted or seen urgently, where heart failure was either the main reason for the visit or a significant complication that made the stay longer - Adults aged 18 or older who have been referred to a ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05743140 · Peking University First Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who have had a coronary angiography (a special X-ray of the heart's blood vessels) performed at the Department of Cardiology, Peking University First Hospital - People whose medical records and background health information are complete - People whose coronary angiography...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05746923 · Jagiellonian University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇵🇱 PL

Who might be able to join this trial: - People who have been admitted to hospital because of acute (sudden or severe) heart failure - People who are older than 18 years of age Who may not be able to join: - People who are unable to give their informed consent to take part in the registry (for example, if they are unab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05752383 · Centre Hospitalier Universitaire, Amiens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who are admitted to an intensive care unit (ICU) due to cardiogenic shock (a condition where the heart suddenly cannot pump enough blood to meet the body's needs) - People whose cardiogenic shock meets the specific definition used by the FRENSCHOCK2 study (confirm with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05753059 · Yale University Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 June 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have been clinically diagnosed with heart failure - People whose doctors have no plans to change or adjust their heart failure medications or devices during the study period - People who have not had an unplanned hospital stay in the past 2 weeks - People whose fl...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05756608 · University of Edinburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2028
🇬🇧 GB

**Who might be able to join this trial:** *Group 1 – Aortic Stenosis (a narrowing of a heart valve):* - You are male or female and aged 50 or older - You have been diagnosed with severe, moderate, or mild aortic stenosis (a narrowing of the main heart valve), or a thickened but not blocked aortic valve - You are willi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05775432 · First Affiliated Hospital Xi'an Jiaotong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2042
🇨🇳 CN

Who might be able to join this trial: - People with severe, end-stage heart failure who have been assessed by doctors at the hospital and approved for a heart transplant on medical and ethical grounds - People who are organ donors providing a heart for transplant Who may not be able to join: - People who do not wish t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05782777 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇰🇷 KR

**Who might be able to join this trial:** - People aged between 19 and 85 years - People who have had a heart artery-opening procedure (coronary revascularization) using a newer type of small mesh tube (drug-eluting stent) to keep the artery open **Who may not be able to join:** - People who have an allergy or sensiti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05783804 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇱 NL

Who might be able to join this trial: - People who have been diagnosed with a genetic condition called heterozygous familial hypercholesterolemia (an inherited form of high cholesterol) - Adults aged between 18 and 50 years old - People whose LDL ("bad") cholesterol level is above 100 mg/dL (or above 2.6 mmol/L) at the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05785897 · IGLESIAS Juan Fernando Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇨🇭 CH

**Who might be able to join this trial:** - People aged 18 or older. - People who were given a combination of two blood-thinning medicines — aspirin and one of three specific medicines (ticagrelor, prasugrel, or clopidogrel) — either when their heart attack was diagnosed or at the latest during their emergency stenting...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05794022 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 June 2033
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been diagnosed with a specific type of heart attack (called STEMI), confirmed by a particular pattern seen on a heart tracing (ECG) test - People whose heart attack is being treated with a primary procedure to open the blocked a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05796739 · Samsung Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2029
🇰🇷 KR

Who might be able to join this trial: - People who are at least 19 years of age - People who have no symptoms but have a high level of calcium buildup in the arteries of the heart, shown by a special scan score of 400 or higher (called an Agatston Score) Who may not be able to join: - People who have had test results...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05800002 · Nanjing First Hospital, Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have silent ischemia (reduced blood flow to the heart with no symptoms), stable or unstable chest pain (angina), or have had a certain type of heart attack — either a non-ST-segment elevation heart attack more than 48 hours ago, or an ST-segment elevation heart att...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05801432 · Asan Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇰🇷 KR

Who might be able to join this trial: - People who are 19 years of age or older - People who have type 2 diabetes with no symptoms and who previously had a heart CT scan (called a CCTA) at the Diabetes Center of Asan Medical Center between February 2008 and June 2012 - People who are willing and able to give written co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05807841 · Asan Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇰🇷 KR

**Who might be able to join this trial:** - People aged 19 years or older - People who have chest pain (angina) with confirmed reduced blood flow to the heart muscle - People who have at least one major heart artery that needs a stent placed in it - People who have signed a consent form agreeing to take part in the stu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05839730 · Medtronic Cardiac Rhythm and Heart Failure Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with heart failure where the heart's pumping function is relatively preserved (the left side of the heart squeezes out at least 55% of its blood with each beat), confirmed by a test done within the last year. - People whose heart failure symptoms fa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05841745 · Clinical Research Center, Intercard Sp. z o.o. Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2023
🇧🇪 BE🇩🇪 DE🇯🇵 JP🇵🇱 PL🇪🇸 ES

Who might be able to join this trial: - Adults older than 18 years old - People who have been diagnosed with either stable coronary artery disease, unstable angina (chest pain that is unpredictable or occurs at rest), or a heart attack - People whose blocked or narrowed heart arteries have been assessed by a doctor as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05845489 · Seoul National University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2028
🇰🇷 KR

**Who might be able to join this trial:** - People aged 40 years or older, of any gender - People who have been found to have early-stage plaque buildup in the arteries of the heart (detected by a heart imaging scan called a coronary CT angiogram or coronary angiogram) within the past 2 years, without having had a hear...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05852509 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 years or older - People who help care for a household member aged 50 or older who has been diagnosed with a heart failure condition (New York Heart Association Class II, III, or IV) - People who provide at least 8 hours per week of unpaid care for that househo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05853419 · Robocath Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇧🇪 BE🇫🇷 FR🇩🇪 DE🇮🇹 IT🇵🇱 PL🇿🇦 ZA

**Who might be able to join this trial:** - People aged 18 years or older - People who have coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked) and have a medical reason to undergo a procedure to open those arteries (called PCI or percutaneous coronary intervention) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05862103 · Yu Bo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2025
🇨🇳 CN

Who might be able to join this trial: - People who previously took part in a specific research project called "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and have already completed their one-year follow-up visit as part of that project - People (o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05866874 · University Hospital, Basel, Switzerland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇭 CH

**Who might be able to join this trial:** - People who are scheduled for routine PMI screening (a type of heart monitoring after surgery — confirm with trial site). - People who will need to stay in hospital for at least 2 nights after their surgery. - People aged between 40 and 85 years old who also have a history of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05868616 · Oslo University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇳🇴 NO

Who might be able to join this trial: - You have been referred to Oslo University Hospital for a specific type of heart device implant (called CRT) or for a follow-up check after having one fitted - Your heart is beating in a normal, regular rhythm (called sinus rhythm) - You have been diagnosed with moderate heart fai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05876000 · Shenzhen Core Medical Technology CO.,LTD. Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇦🇹 AT🇩🇪 DE🇮🇹 IT

Who might be able to join this trial: - People aged 18 to 75 years old. - People who have signed a consent form agreeing to take part in the study. - People with a body surface area (a measure of body size based on height and weight) of at least 1.2 m². - People with the most severe class of heart failure symptoms, kno...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05897333 · Gazi University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2032
Turkey (Türkiye)

Who might be able to join this trial: - People who have a condition where their coronary arteries (the blood vessels supplying the heart) are abnormally enlarged or widened, but without significant narrowing in those arteries. - People with this enlarged coronary artery condition, whether or not they have recently had...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05897632 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - People aged 21 years or older - People experiencing chest pain or other symptoms that could suggest a possible heart attack - People whose risk score for a heart attack (called a HEART score) falls between 4 and 6, indicating a moderate level of risk - People whose heart tracing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05908331 · Concept Medical Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇺🇸 US

**Who might be able to join this trial:** - People who are at least 18 years old - People (or their legal guardian) who understand what the trial involves and agree to take part in writing before any trial-related tests or treatment begin - People who need a procedure to open a blocked coronary artery (called PCI) bec...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05916898 · Regional Cardiology Center, The Copper Health Centre (MCZ), Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇵🇱 PL

Who might be able to join this trial: - People who have moderately to severely calcified (hardened) blockages in a coronary artery (a blood vessel supplying the heart). - People whose previously implanted stent (a small mesh tube used to keep an artery open) has not expanded properly, meaning it is more than 20% narrow...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05918380 · University Hospitals Cleveland Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

**Who might be able to join this trial:** - People between 40 and 75 years of age - People who identify as Black or African American - People who live in the Cleveland Metro Area - People who were identified at a University Hospitals (UH) health fair screening as having at least two of the following health risk factor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05918861 · DalCor Pharmaceuticals Phase 3 · 3 countries Recruiting
Recruiting Phase 3 Est. completion 1 August 2027
🇨🇦 CA Puerto Rico🇺🇸 US

**Who might be able to join this trial:** - People who have a specific genetic background and have been hospitalised for a serious heart event called an acute coronary syndrome (ACS) within the past 3 months - People aged 45 years or older at the screening visit, both male and female - People whose genetic test (calle...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05925634 · Baystate Medical Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 July 2026
🇺🇸 US

**Who might be able to join this trial:** - You have had a heart-related event in the past 6 months, such as a heart attack, heart failure, a procedure to open blocked arteries (with or without a stent), heart bypass surgery, or heart valve surgery. - You currently live in, or plan to live in, the Springfield, MA or gr...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05931614 · Region Stockholm Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇸🇪 SE

Who might be able to join this trial: - People who have been diagnosed with left-sided heart failure where the heart muscle is weakened (specifically the types known as HFrEF or HFmEF). - People who are physically able, mentally able, and able to communicate in the study language well enough to take part in all parts o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05934565 · Beth Israel Deaconess Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with COPD, meaning they have a smoking history of more than 10 pack-years (a measure of how much someone has smoked over time) and either a specific breathing test result showing reduced airflow, or a chest CT scan showing signs of emphysema (l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05955456 · Manchester University NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2030
🇬🇧 GB

**Who might be able to join this trial:** - People who have signed a written consent form agreeing to take part in the study - People aged 50 or older - People who have been diagnosed with two or more of the following conditions: type 2 diabetes, chronic obstructive pulmonary disease (a lung condition), ischaemic heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05960968 · Fundacion de la Sociedad Chilena de Cardiologia y Cirugia Cardiovascul... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇱 CL

**Who might be able to join this trial:** - People aged 18 years or older - People who have signed a consent form agreeing to take part in the study - People who have been admitted to hospital where the main reason for admission is a sudden worsening of heart failure, and where the treating doctor has prescribed a hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05961488 · CHU de Reims Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who have been admitted to an intensive care unit after their heart stopped outside of a hospital and was successfully restarted - People where no clear cause for the cardiac arrest has been found after reviewing their medical history, a brain scan, and a lung blood ves...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05967663 · RenJi Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older - People who have had a specific type of heart attack (called STEMI) and have blockages in multiple heart arteries, where the main blocked artery causing the heart attack has already been successfully treated with a procedure to open it up (including p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05971225 · Saint Vincent's Hospital, Korea Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2026
🇰🇷 KR

Who might be able to join this trial: - People diagnosed with heart failure where the heart's pumping ability is reduced (specifically, where the pumping function is measured at 40% or below), who are over 20 years old and have a Biotronik brand heart device (such as an ICD or CRT) that is capable of wireless monitorin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05978388 · Tor Biering-Sørensen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇩🇰 DK

Who might be able to join this trial: - People who are 18 years of age or older. - People who have been referred for a catheter ablation procedure (not including AV-junction ablation) for atrial fibrillation — either the type that comes and goes (paroxysmal) or the longer-lasting type (persistent) — at the Department o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05986968 · Radboud University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇳🇱 NL

Who might be able to join this trial: - People who have been diagnosed with a type of heart attack called a STEMI, confirmed by clinical assessment and a heart tracing (ECG) - People who have had a successful procedure to open the blocked heart artery (called PCI), with a modern type of stent placed, as determined by t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05997693 · Weill Medical College of Cornell University Phase 3 · 6 countries Recruiting
Recruiting Phase 3 Est. completion 1 January 2027
🇦🇹 AT🇨🇦 CA🇨🇳 CN🇩🇪 DE🇸🇪 SE🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - You are scheduled for your first heart bypass surgery (CABG) that is planned in advance (not an emergency), and at least one vein from your leg will be used during the surgery - You are able to give your consent to participate and are willin...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06002932 · Saint Vincent's Hospital, Korea Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2028
🇰🇷 KR

Who might be able to join this trial: - People aged 19 years or older. - People who have a specific type of blocked artery at a branching point in the heart, where the branch vessel measures between 2.25 and 2.75 mm wide, the main vessel is at least 2.5 mm wide, and the blockage meets a specific pattern called a "true...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06007950 · Universiti Teknologi Mara Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2024
🇲🇾 MY

**Who might be able to join this trial:** - You are between 18 and 65 years old - You have previously had a heart attack or a serious heart-related emergency (known as acute coronary syndrome) - Your health is currently stable - You typically spread your eating across at least 12 hours of the day (for example, eating f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06009718 · Ruijin Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇨🇳 CN

Who might be able to join this trial: - People who attended RuiJin Hospital for an ultrasound heart scan (called an echocardiogram) - People who have signed and dated a consent form agreeing to take part - People who are willing to follow all the study steps and take part in the full process - People who have already c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06009809 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇮🇹 IT

Who might be able to join this trial: - Adults over 18 years of age - People who are able to give written consent to participate - People who are scheduled to have heart surgery using a heart-lung bypass machine - People whose heart failure symptoms fall into a mild-to-moderate category (rated as Class I, II, or III on...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06019169 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older - People living with chronic heart failure, where the heart's pumping function (measured as LVEF) is 50% or below - People whose heart failure has been stable for more than one month, with no recent hospital admission for heart failure in the past mon...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06024746 · Colorado Prevention Center Phase 3 · 3 countries Recruiting
Recruiting Phase 3 Est. completion 1 July 2026
🇧🇷 BR🇨🇦 CA🇺🇸 US

**Who might be able to join this trial:** - People who are willing and able to give consent (either personally or through an authorised representative, as allowed by local rules) - People aged 18 or older (or the legal age of adulthood in their country) - People who are currently in hospital, or who have recently been...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06032780 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇵🇰 PK

**Who might be able to join this trial:** - People who have been diagnosed with chronic (long-term) heart failure and whose condition is currently stable with the best available medical treatment - People whose heart is still pumping at least 30% of its normal capacity (a measurement called ejection fraction) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06036615 · Aristotle University Of Thessaloniki Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇬🇷 GR

Who might be able to join this trial: - Adults over 18 years of age, of any gender - People who have been diagnosed with heart failure (either with reduced or preserved pumping function), confirmed by a heart ultrasound (echocardiogram) - People whose heart failure causes symptoms such as breathlessness or fatigue duri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06055504 · Consorcio Centro de Investigación Biomédica en Red (CIBER) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇪🇸 ES

**Who might be able to join this trial:** - You are 18 years of age or older at the time of screening. - You have already been diagnosed with a type of heart condition called non-ischemic dilated cardiomyopathy (a weakened, enlarged heart not caused by blocked arteries). - You have been on the best possible heart medic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06058182 · IRCCS Policlinico S. Donato Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2026
🇮🇹 IT

Who might be able to join this trial: - Adults over 18 years of age. - People who have been diagnosed with their first episode of Acute Coronary Syndrome (ACS — a term for conditions where blood flow to the heart is suddenly reduced or blocked), as defined by European heart disease guidelines from 2017. - People whose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06059664 · University of North Carolina, Chapel Hill Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 March 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who have received a kidney transplant (from either a living or deceased donor) between 1 and 10 years ago - People whose transplanted kidney is working at a stable and consistent level, as determined by their doctor - People whose transplanted kidney is fu...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06066970 · Jena University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇩🇪 DE

**Who might be able to join this trial:** - You have been recommended for surgery on either your aortic valve or mitral valve (one valve only, not combined with other heart procedures) - You are 18 years of age or older - You are willing and able to give written consent to take part **Who may not be able to join:** -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06068764 · Hartford Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - You are scheduled for a planned (non-emergency) open heart bypass surgery (CABG) - You have been given a general health rating between I and IV by your anesthesia team (this covers a wide range of health conditions) - You are able to speak and read both English and Spanish *...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06070662 · University of Leicester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇬🇧 GB

**Who might be able to join this trial:** - People who are already taking part in the 'CMR versus CT-FFR in CAD' study - People aged 18 or older - People who have been referred for an invasive coronary angiography (a procedure to look at the heart's arteries) to investigate chest pain - People who are willing and able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06074549 · Elixir Medical Corporation Not Applicable · 9 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇦🇹 AT Curacao🇮🇩 ID🇮🇹 IT🇯🇴 JO🇸🇦 SA Turkey (Türkiye)🇦🇪 AE +1 more

Who might be able to join this trial: - People who are over 18 years of age - People who understand what the trial involves and agree to take part by signing a consent form - People for whom a doctor has recommended a heart procedure (called PCI) that involves placing a stent, and who would receive at least one specifi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06075160 · Sejong General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇰🇷 KR

**Who might be able to join this trial:** - People who have a moderate blockage in a coronary artery (estimated at 50–90% narrowing) and whose doctor has decided that a procedure guided by a specific heart pressure measurement (called RFR) is clinically needed - People who have chosen to take part in the study on their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06075420 · Genoss Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇰🇷 KR

Who might be able to join this trial: - People aged 19 or older - People who have coronary artery disease and have been treated with a GENOSS SES (a type of heart stent) - People who are willing to take part, agree to follow the study plan including scheduled check-ups, and sign a written consent form Who may not be a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06076551 · Korea University Anam Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇰🇷 KR

Who might be able to join this trial: - People who experience typical or atypical chest pain, or symptoms that may suggest reduced blood flow to the heart, including shortness of breath - People whose coronary angiogram or CT scan has shown no significant blockages in the heart's arteries (less than 50% narrowing) Who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06089577 · Federico II University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 October 2025
🇮🇹 IT

**Who might be able to join this trial:** - Adults (18 years of age or older) - People who have given written consent to participate in the study - People with chronic (long-term, stable) coronary artery disease — meaning heart artery problems that are not caused by a recent or emergency heart event - People who have n...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06089902 · University of Padova Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 January 2025
🇮🇹 IT🇨🇭 CH

Who might be able to join this trial: - People who have been diagnosed with an abnormal origin of a coronary artery from the opposite side of the heart (known as AAOCA), whether they have been referred for surgery or are being monitored without surgery. Who may not be able to join: - People whose coronary artery conne...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06092437 · Zuyderland Medisch Centrum Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 June 2026
🇳🇱 NL

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with heart failure (any type — where the heart pumps weakly, moderately weakly, or with a stiff heart muscle), diagnosed using recognised European heart failure guidelines - People who are currently experiencing an epis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06099158 · Tor Biering-Sørensen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇩🇰 DK

Who might be able to join this trial: - People who have a heart device (either a CRT-D or ICD) implanted that has a feature called HeartLogic, and where that feature can be turned on or off as part of the trial - People who are 18 years of age or older - People who regularly use remote heart monitoring and are actively...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06101862 · Rigshospitalet, Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇩🇰 DK

Who might be able to join this trial: - People who have been admitted to hospital with a type of heart condition called a non-ST-elevation heart attack or unstable angina, and who have been recommended for a non-urgent heart artery imaging procedure. - People who have a blood test result showing elevated troponin (a ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06105580 · Hospital Clinic of Barcelona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇪🇸 ES

**Who might be able to join this trial:** - People who are willing to participate and have signed a consent form agreeing to take part in the study. - People who are 18 years of age or older. - People who have a specific heart electrical conduction problem called left bundle branch block, with certain measurements of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06114615 · University of California, Davis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

"Who might be able to join this trial: - People who have been diagnosed with coronary heart disease, have undergone a procedure called PCI (a minimally invasive procedure to open blocked heart arteries), and attend follow-up appointments at University of California Davis Health. Who may not be able to join: - No speci...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06122779 · Bristol-Myers Squibb Phase 2 · 11 countries Recruiting
Recruiting Phase 2 Est. completion 14 December 2026
🇦🇷 AR🇨🇦 CA🇨🇳 CN🇮🇱 IL🇮🇹 IT🇯🇵 JP🇵🇱 PL🇰🇷 KR +3 more

**Who might be able to join this trial:** - Adults who have been diagnosed with stable heart failure with preserved ejection fraction (HFpEF) — a type of heart failure where the heart still pumps a normal amount of blood but does not relax properly — and who are experiencing symptoms from this condition **Who may not...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06125392 · Johannes Gutenberg University Mainz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2028
🇩🇪 DE

Who might be able to join this trial: - People who have had both blood pressure and blood flow measured inside at least one of their own (non-bypassed) heart arteries, tested using two different types of medications that cause the arteries to widen. Who may not be able to join: - People whose blood pressure or circula...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06130059 · University of Texas Southwestern Medical Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 years or older at the time of signing the consent form - People who have a blood marker of inflammation (called hs-CRP) measured at 2 mg/L or above at the start of the study - People who have been diagnosed with a long-term heart condition called HFpEF (heart...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06136637 · University Hospital, Rouen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇫🇷 FR

Who might be able to join this trial: - Adults aged 18 years or older - People who are scheduled to have heart surgery using a heart-lung bypass machine, where the bypass is expected to last more than 60 minutes - People who have been informed about the study and have not objected to taking part, at least the day befor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06143332 · Western University, Canada Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇨🇦 CA

**Who might be able to join this trial:** - You have been diagnosed with coronary artery disease (a condition affecting the blood vessels of the heart), but your heart's pumping function is still within a normal range - You were recently admitted to hospital and treated for a heart attack, and have since been discharge...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06148571 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇰🇷 KR

Who might be able to join this trial: - People who have previously been diagnosed with a type of heart failure where the heart is not pumping as well as it should, confirmed by a heart ultrasound scan showing the heart's pumping strength is below 50% - People who have been assessed as needing a pacemaker or a device th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06154395 · Harbin Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

Who might be able to join this trial: - Adults aged 18 years or older. - People who have been newly diagnosed with a specific type of heart attack (called an anterior wall STEMI) where symptoms started within the last 6 hours, and who are being treated with an emergency procedure to open the blocked artery (called prim...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06161402 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
Hong Kong

Who might be able to join this trial: - People aged 50 or older - People who have had a confirmed diagnosis of heart failure recorded in their medical records for at least 6 months - People whose grip strength is below a certain level (under 28kg for men, under 18kg for women), who score 9 or below on a physical functi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06166654 · Johannes Grand Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2027
🇩🇰 DK

Who might be able to join this trial: - Adults aged 18 or older - People admitted to hospital with a diagnosis of acute heart failure where the body is retaining excess fluid - People showing signs that their water tablets (diuretics) may not be working well enough, which means either having taken daily diuretics by mo...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06169540 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** *For people with stable chronic heart failure (CHF):* - People who are at least 18 years old - People who have been diagnosed with any type of chronic heart failure, are in a stable condition, and have specific blood marker levels (called NT-proBNP) that fall within ranges det...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06180603 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇩🇰 DK

Who might be able to join this trial: - Adults aged 18 or older who are admitted to an emergency department - People who have a build-up of fluid around the lungs, detected by an ultrasound, chest X-ray, or CT scan - People for whom a doctor has determined that draining the fluid is medically necessary — either to reli...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06182683 · Korea University Guro Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇰🇷 KR

Who might be able to join this trial: - People who are older than 19 years of age - People who are having a coronary stent procedure to treat stable angina or an acute coronary syndrome (a serious heart condition including heart attacks) - People who have given their informed consent to take part Who may not be able t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06182839 · McGill University Health Centre/Research Institute of the McGill Unive... Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 March 2028
🇨🇦 CA

Who might be able to join this trial: - People with advanced kidney disease, meaning their kidneys are working at less than 20% of normal capacity and they are not yet on dialysis, OR people who started dialysis (either hemodialysis or peritoneal dialysis) within the last 6 months. (Note: for people who started dialysi...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06185530 · London North West Healthcare NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇬🇧 GB

Who might be able to join this trial: - People who are over 18 years old - People who have been referred to a rapid-access chest pain clinic and, after review, have been identified as needing further heart imaging — either a stress echocardiogram (a type of ultrasound of the heart during exercise) or a CT scan of the h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06190834 · Beijing Tsinghua Chang Gung Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇨🇳 CN

Who might be able to join this trial: - You are 18 years of age or older - You have been diagnosed with coronary artery disease (a condition affecting the blood vessels of the heart), confirmed by a specific imaging test called a coronary angiography Who may not be able to join: - You have been diagnosed with any of t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06208007 · University Medical Center Goettingen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇩🇪 DE

Who might be able to join this trial: - People who are older than 60 years - People who have high blood pressure (either a top number of 140 or more, a bottom number of 90 or more, or who take 2 or more blood pressure medications) - People who have Type 1 or Type 2 diabetes - People who have a heart rhythm condition ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06215989 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years of age or older - You have been definitively diagnosed with Acute Coronary Syndrome (ACS — a condition such as a heart attack or unstable chest pain caused by reduced blood flow to the heart) - You are able and willing to sign a written consent form agreeing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06216847 · Shenyang Northern Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been admitted to hospital with confirmed or suspected coronary heart disease (a condition affecting the blood vessels of the heart), and who also have at least one of the following: a history of a procedure to open bl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06249945 · National Taiwan University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇹🇼 TW

Who might be able to join this trial: - People who are 20 years of age or older - People who have end-stage kidney disease and have been on regular, ongoing dialysis with a stable fluid removal target (dry weight) for the past 6 months - People who have previously been diagnosed with a specific type of heart failure ca...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06253962 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

"Who might be able to join this trial: - People who receive both a carotid ultrasound (a scan of the blood vessels in the neck) and a coronary angiography (an imaging test that looks at the blood vessels of the heart). Who may not be able to join: - There are no listed exclusion criteria for this trial. Important: Al...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06255769 · Qilu Hospital of Shandong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2024
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 years or older - People who have chest pain or other symptoms suggesting reduced blood flow to the heart, and whose coronary artery imaging (either a catheter-based test or a CT scan) has shown that any narrowing in the arteries is less than 70% (not severely b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06275386 · National Institute of Cardiology, Warsaw, Poland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇵🇱 PL

**Who might be able to join this trial:** - People for whom the local heart team has determined that a procedure to open a completely blocked coronary artery (called a CTO PCI) is medically appropriate, based on symptoms such as chest pain or proven reduced blood flow or living heart tissue in the affected area. - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06282042 · Fundación para la Investigación Biosanitaria del Principado de Asturia... Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 16 June 2027
🇮🇱 IL🇮🇹 IT🇳🇱 NL🇪🇸 ES

**Who might be able to join this trial:** - People who have moderate to severe or severe mitral regurgitation (a leaky heart valve) that is causing symptoms, which developed after a heart attack - People who are older than 18 years - People whose condition falls into a specific category (Type 2, 3, or 4) based on a pub...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06283420 · Vojtech Melenovsky, MD, PhD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2025
🇨🇿 CZ

**Who might be able to join this trial:** - People who are able to give written consent to participate in the study - People who have been diagnosed with heart failure (classified as NYHA class II, III, or IV — meaning symptoms ranging from mild to severe) for more than 3 months, regardless of the type of heart failure...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06286423 · University of Virginia Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People who were admitted to hospital primarily because of a sudden worsening of heart failure, confirmed by symptoms plus at least one of: fluid buildup in the lungs seen on exam or chest X-ray, specific measurements on a heart ultrasound, pressure readings from a heart proc...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06286878 · University of Sao Paulo Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 July 2025
🇧🇷 BR

**Who might be able to join this trial:** - Adults aged 18 or older (women who could become pregnant must have a negative pregnancy test result) - People already taking two blood-thinning medications together — aspirin plus a second type called an ADP receptor antagonist — as part of their usual care - People diagnosed...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06302777 · Goethe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 September 2028
🇩🇪 DE

**Who might be able to join this trial:** - People who are having a pre-procedure imaging scan called optical coherence tomography (a type of detailed scan used to look inside blood vessels or tissue before a medical procedure is carried out) **Who may not be able to join:** - No specific exclusion criteria have been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06304857 · 4th Military Clinical Hospital with Polyclinic, Poland Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2026
🇵🇱 PL

**Who might be able to join this trial:** - People who are older than 18 and younger than 80 years of age. - People who have been diagnosed with invasive breast cancer (stage I, II, or III) and who are planned to start a type of chemotherapy called anthracycline within 60 days. - People who have signed a consent form a...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06308055 · Abiomed Inc. Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇩🇪 DE🇮🇹 IT🇨🇭 CH

Who might be able to join this trial: - You are currently in intensive care or are planned to receive intensive care with a device called an Impella (a small heart pump) to support your heart. - You already have, or are planned to have, a way of measuring how well your heart is pumping blood (called cardiac output), su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06310031 · BrioHealth Solutions, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older. - People who have been approved by their hospital to receive a left ventricular assist device (LVAD), which is a mechanical pump that helps the heart work. - People whose body surface area (a measure based on height and weight) is at...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06311461 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with stable angina or a chest pain condition for at least 1 month (this includes pain, pressure, or discomfort in the chest or other parts of the upper body). - People who have been receiving medical treatment for this condition for at least 1 month...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06316349 · University of Sao Paulo General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 18 March 2025
🇧🇷 BR

Who might be able to join this trial: - Adults aged 18 or older - People who have had an intra-aortic balloon pump (a device placed in the aorta to help the heart pump blood) in place for more than 48 hours - People receiving a heart-stimulating medication called dobutamine at a low dose (no more than 20 mcg/kg/min) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06336317 · Region Örebro County Phase 4 · 3 countries Recruiting
Recruiting Phase 4 Est. completion 1 December 2027
🇩🇰 DK🇸🇪 SE🇬🇧 GB

**Who might be able to join this trial:** - People who have been diagnosed with a type of heart attack called a non-ST-segment elevation myocardial infarction (a specific kind of heart attack — confirm with trial site if unsure which type applies) - People who have completed a heart procedure called coronary PCI (a pr...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06336746 · Karlstad Central Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇸🇪 SE

**Who might be able to join this trial:** - Adults who are scheduled to have robotic surgery that requires lying in a head-down (tilted) position during the procedure **Who may not be able to join:** - People under 18 years of age - People who have dementia - People who are not able to provide written consent to parti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06338293 · Nanjing First Hospital, Nanjing Medical University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2025
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 80 years old - A heart artery scan (coronary angiography) showed a partial blockage of 20–70% in a main heart artery, and further detailed imaging confirmed at least one unstable or "at-risk" fatty plaque in that artery, but the artery does not need a s...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06338696 · Mahidol University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇹🇭 TH

**Who might be able to join this trial:** - You must be older than 18 years of age. - You must have been diagnosed with a condition called ATTR cardiomyopathy (a disease where a protein called transthyretin builds up in the heart), whether or not you currently have symptoms. - Your heart must show signs of involvement...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06342492 · Kansas City Heart Rhythm Research Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2024
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People who have heart failure with reduced pumping ability and received a type of heart rhythm device called cardiac resynchronisation therapy (CRT) using a standard vein-based lead placement - People who had a lead (the wire connecting the device...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06343844 · University Hospital, Angers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2039
🇫🇷 FR

Who might be able to join this trial: - Adults over 18 years of age. - People who have had their first heart attack of a specific type (called an ST-segment elevation myocardial infarction) while already in hospital. - People who have had a procedure to examine their heart's arteries (called a coronary angiography) wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06349941 · University of Texas Southwestern Medical Center Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2028
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People who have been admitted to hospital for acute heart failure at least once in the past 12 months - People who are able to attend medical appointments conducted by video or phone (telemedicine) - People who have access to a smartphone or other...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06353594 · Hospital Universitario La Fe Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇪🇸 ES

**Who might be able to join this trial:** - People who are having a specific type of serious heart attack (called a STEMI) and who need an emergency procedure to open a blocked artery (called a primary PCI, which uses a small tube and balloon to restore blood flow) **Who may not be able to join:** - People who are exp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06359938 · Ceryx Medical Ltd Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇬🇧 GB

Who might be able to join this trial: - Adults aged 22 years or older who are scheduled to have coronary artery bypass graft (CABG) surgery — a type of open-heart surgery to improve blood flow to the heart — using a heart-lung bypass machine - People who have been diagnosed with heart failure where the heart's pumping...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06364150 · Seoul National Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 May 2025
🇰🇷 KR

**Who might be able to join this trial:** - People aged 19 to 80 years, either male or female - People who have been clinically diagnosed with a heart attack within the past 4 weeks before being enrolled in the trial - People who have had a successful procedure to open a blocked heart artery (resulting in good blood fl...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06365502 · Harbin Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People between 18 and 80 years of age - People who have had a heart attack or severe chest pain (unstable angina) and are planned to have a procedure to open blocked arteries (called PCI, or percutaneous coronary intervention) - People who have had stents successfully placed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06373601 · Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇮🇹 IT

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with stable chest pain (chronic stable angina) or a recent heart event that has since been stabilised, with heart enzyme blood test results back within normal range - People who have at least one new (previously untrea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06377449 · Saint Petersburg State University, Russia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 May 2025
🇷🇺 RU

Who might be able to join this trial: - People who had open heart surgery using a heart-lung bypass machine (a machine that temporarily takes over the work of the heart and lungs) between 15 December 2023 and 15 December 2024 - People who have signed a consent form agreeing to take part in the study Who may not be abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06377761 · Guangdong Provincial Hospital of Traditional Chinese Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who are willing and able to sign a consent form agreeing to take part in the study - People aged between 18 and 85 years old - People who have been diagnosed with heart failure for at least 3 months before joining, and whose heart failure symptoms fall into a moderate-to-s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06381427 · University of Giessen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇩🇪 DE

**Who might be able to join this trial:** - People aged 65 years or older - People scheduled for a planned (non-emergency) non-heart surgery that carries an intermediate or high level of risk, performed under general anaesthesia or a combination of general and regional anaesthesia - People with an ASA health classifica...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06388226 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 August 2026
🇺🇸 US

**Who might be able to join this trial:** - You are a man or woman aged 18 or older - You have been diagnosed with a type of heart failure called "heart failure with preserved ejection fraction" (HFpEF), meaning your heart pumps normally but doesn't relax properly, confirmed by a heart ultrasound and/or other heart mea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06388668 · Montreal Heart Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇨🇦 CA

Who might be able to join this trial: - Adults aged 18 years or older - People who are currently admitted to a Cardiac Care Unit due to a heart attack (either a type called NSTEMI or STEMI) - People who had a blood test to check cholesterol and fat levels done on the first day of their hospital admission - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06393894 · Pauls Stradins Clinical University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇱🇻 LV

**Who might be able to join this trial:** - People who have given written consent to participate - People who have been diagnosed with early atherosclerosis (fatty buildup in the heart's arteries), defined as men under 55 years old or women under 65 years old with this condition - People whose heart arteries have been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06399692 · Weill Medical College of Cornell University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 15 March 2033
🇺🇸 US

Who might be able to join this trial: - The person must be female. - The person must be at least 18 years old. - The person must have coronary artery disease affecting multiple blood vessels or the main artery of the heart, where the medical team has determined that either open-heart bypass surgery or a stenting proced...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06399705 · Weill Medical College of Cornell University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 15 March 2033
🇺🇸 US

**Who might be able to join this trial:** - You identify as a member of a minority group - You are 18 years old or older - You have been found to have blockages in multiple heart arteries or in the main heart artery (left main), and your heart care team has decided that either open-heart bypass surgery (CABG) or a sten...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06410690 · Centro Cardiologico Monzino Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇮🇹 IT

**Who might be able to join this trial:** - Adults aged 18 or older who have known or suspected coronary artery disease (a condition affecting the heart's blood vessels) and have been referred by their doctor for diagnostic testing - People whose heart scan (called a CCTA — a specialised CT scan of the heart) is perfor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06414551 · Sandwell & West Birmingham Hospitals NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇬🇧 GB

Who might be able to join this trial: - Adults aged 18 or older - People who have had a procedure attempted to open a completely blocked heart artery (called a CTO procedure) within the last 5 years - People who have had a special type of heart CT scan (called a CTCA, or coronary CT angiogram) either before or after th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06420505 · Translumina GmbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 November 2026
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older - People who are able to sign a consent form agreeing to take part - Men, or women who are not pregnant (women of childbearing age will be asked verbally about pregnancy status) - People who have presented with a heart condition involving blocked or na...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06436053 · Abbott Medical Devices Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
🇮🇹 IT

**Who might be able to join this trial:** - People who are 18 years of age or older and are willing to follow the study requirements - People who have a medical reason to receive a dual-chamber pacemaker or cardiac resynchronization therapy device, and are scheduled to have an Abbott pacing device implanted - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06436092 · TCROSS Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇯🇵 JP

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with stable coronary artery disease, a type of heart attack called non-ST-elevation myocardial infarction, or unstable angina (chest pain caused by reduced blood flow to the heart) - People whose left main coronary art...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06441760 · Boston Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

Who might be able to join this trial: - Emergency Medical Technicians (EMTs), Advanced EMTs, and Paramedics who respond directly to emergency scenes may be eligible to participate. - Specialist emergency doctors (in either Pediatric Emergency Medicine or general Emergency Medicine) whose work includes providing remote...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06441942 · IRCCS San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2026
🇮🇹 IT

**Who might be able to join this trial:** - Women aged 18 or older who have been diagnosed with a type of heart condition called Acute Coronary Syndrome (ACS), which includes heart attacks (STEMI or NSTEMI) or a serious type of chest pain called Unstable Angina **Who may not be able to join:** - People under 18 years...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06444321 · Vestre Viken Hospital Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇳🇴 NO

**Who might be able to join this trial:** - People who are over 18 years old - People who have been admitted to hospital with heart failure that has gotten worse, with symptoms such as shortness of breath, fluid build-up (such as swelling), or signs of congestion in the lungs, along with elevated levels of a specific h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06445231 · Nantes University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇫🇷 FR

Who might be able to join this trial: - People who live in a nursing home and are expected to live for more than one year - People who are able to take part in the study and have given their spoken agreement to do so Who may not be able to join: - People for whom an echocardiogram (a heart ultrasound scan) cannot be p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06445608 · Kardion Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 90 years old at the time of screening - People whose heart's pumping strength (left ventricular ejection fraction) is below 50%, measured within the 90 days before the procedure - People who are considered high-risk due to one or more of the following heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06451198 · Shanghai Zhongshan Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2028
🇨🇳 CN

**Who might be able to join this trial:** - People who are over 65 years old - People who have been diagnosed with a type of heart condition called acute coronary syndrome (this includes unstable angina, or a heart attack with or without a specific pattern on a heart tracing test) - People who have been treated with at...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06471036 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - You are 18 years of age or older - You were admitted to the hospital with a specific type of heart attack (called NSTEMI Type 1 or STEMI) and/or had a procedure to open blocked heart arteries (such as a stent) - Your LDL ("bad") cholesterol level was 70 mg/dL or higher during you...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06475456 · Fondazione GISE Onlus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 November 2026
🇮🇹 IT

**Who might be able to join this trial:** - People aged 18 to 75 years old - People who are conscious and able to sign and date a consent form agreeing to take part and to their personal data being used - People who are unconscious, where a legal representative, proxy, or relative has signed and dated a consent form o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06479876 · Vanderbilt University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People diagnosed with Stage C heart failure with symptoms ranging from mild to moderate (NYHA Class I–III), who have recently been discharged from a hospital stay due to heart failure, OR have an upcoming cardiology appointment and have been hospitalised for heart failure in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06494163 · Ottawa Heart Institute Research Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇦 CA

**Who might be able to join this trial:** - Women (people who were assigned female sex at birth) who have been diagnosed with coronary heart disease — for example, those who have had heart bypass surgery, a stent procedure, a heart attack, or certain types of reduced blood flow to the heart — at least 4 weeks after th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06501287 · Fatma Madhy Eissa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 December 2024
🇪🇬 EG

**Who might be able to join this trial:** - People who have been diagnosed with coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked), confirmed through a heart imaging procedure, blood tests, and a heart tracing test (ECG) **Who may not be able to join:** - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06501768 · University Medical Centre Ljubljana Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇸🇮 SI

**Who might be able to join this trial:** - People who have heart failure (caused either by blocked arteries or by other heart conditions) where the heart's pumping strength is below 40% - People who have a heart condition called ATTR cardiomyopathy (a disease where abnormal proteins build up in the heart), regardless...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06503640 · China-Japan Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

Who might be able to join this trial: - People who have stable chest pain (angina) symptoms, have a medical reason to undergo an invasive heart artery imaging procedure, and whose results show no significant blockages in the main heart arteries (measured using a test called FFR, with a result above 0.80) Who may not b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06512493 · Radboud University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2050
🇳🇱 NL

Who might be able to join this trial: - This trial does not list any specific requirements that participants must meet in order to join (confirm with trial site) Who may not be able to join: - This trial does not list any specific conditions that would prevent someone from joining (confirm with trial site) Important:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06513611 · Hospital de Clinicas José de San Martín Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇦🇷 AR

**Who might be able to join this trial:** - People over 21 years of age who have been admitted to the Coronary Unit of the Hospital de Clínicas with a diagnosis of Acute Coronary Syndrome (a serious heart condition caused by reduced blood flow to the heart). - People who agree to take part and sign a consent form confi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06518694 · Assistance Publique - Hôpitaux de Paris Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 October 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People who have had a confirmed heart failure diagnosis for more than 12 months, whether caused by a blocked blood supply to the heart or another cause - People whose heart was previously pumping weakly (with a pumping strength of 45% or less), but...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06520904 · First Affiliated Hospital of Xinjiang Medical University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - Men between 18 and 55 years old, or women between 18 and 65 years old. - People diagnosed with coronary artery disease (blockages in the heart's arteries), where imaging has confirmed narrowing in 2 or more arteries, with at least one artery having a 50–70% blockage. - People...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06522594 · Erasmus Medical Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2025
🇳🇱 NL

**Who might be able to join this trial:** - Adults aged 18 or older - People who are receiving a type of heart-lung bypass support called V-A ECMO (a machine that helps pump blood when the heart is too weak) due to severe heart failure affecting the left side or both sides of the heart - People who started V-A ECMO su...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06529848 · Bispebjerg Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2027
🇩🇰 DK

**Who might be able to join this trial:** - People who have been found to have poor blood flow through the small vessels of the heart (called coronary microvascular dysfunction), based on a specific type of heart scan called a PET scan - People who do not have significant blockages in their major heart arteries **Who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06532825 · University Hospital Bispebjerg and Frederiksberg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇩🇰 DK

Who might be able to join this trial: - Adults aged 18 years or older - People admitted to hospital with a sudden worsening of heart failure within the last 48 hours Who may not be able to join: - People who have a pacemaker - People who have not signed the informed consent form agreeing to take part in the trial - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06535503 · Abu Dhabi Health Services Company Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2025
🇦🇪 AE

Who might be able to join this trial: - People aged 18 or older. - People who had a specific type of heart attack (called STEMI) that was complicated by a serious condition where the heart could not pump enough blood (called cardiogenic shock). - People who were hospitalised or treated at SSMC or SKMC for this type of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06535568 · Fondazione Ricerca e Innovazione Cardiovascolare ETS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 January 2028
🇮🇹 IT

Who might be able to join this trial: - People aged 75 or older, or people aged 18 or older who have a high risk of bleeding - People who have just had a successful procedure (called PCI) using a specific medical device called the Essential Pro DCB, treating 1, 2, or 3 heart arteries - People with stable or unstable he...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06537583 · Universitas Diponegoro Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2024
🇮🇩 ID

Who might be able to join this trial: - People who have had a specific type of heart attack (called a STEMI) that started less than 12 hours ago - People who have agreed to take part in the study - People whose heart and circulation are relatively stable on arrival, classified as Killip class I or II (confirm with tria...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06540521 · Medtronic Cardiac Rhythm and Heart Failure Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 years or older - People who are willing to give their informed consent to take part in the study - People who have had a specific type of heart pacing therapy called LBBAP (a lead placed on the left side of the heart's lower chambers) for at least 1 month but n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06542653 · The First Affiliated Hospital with Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 17 September 2024
🇨🇳 CN

Who might be able to join this trial: - People who had at least one completely blocked coronary artery (a type of long-term, total blockage called a CTO) treated at the relevant hospital between January 2011 and December 2017 Who may not be able to join: - People who had a severe type of heart attack called an ST-segm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06543082 · CHA University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2028
🇰🇷 KR

**Who might be able to join this trial:** - People who have had a heart attack or acute coronary syndrome with a positive troponin blood test result, and who have had a specific type of heart stent placed (called an Orsiro stent, made by Biotronik AG). - People who have signed a written consent form agreeing to take pa...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06543173 · University of Rochester Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 1 August 2030
🇩🇰 DK🇫🇷 FR🇪🇸 ES

Who might be able to join this trial: - You are 18 years of age or older (there is no upper age limit) - You are willing and able to give your informed agreement to take part in the study - Your doctor has recommended you as a candidate for a type of heart device (ICD or CRT-D) to help prevent a serious heart event bef...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06552637 · VisCardia Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇺🇸 US

Who might be able to join this trial: - People whose heart failure symptoms fall into a moderate category (NYHA Class II or III) and who are already on the best available standard heart failure medications - People whose heart's electrical signal width (QRS duration) is 130 milliseconds or less - People whose heart pum...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06558474 · Cathreine BV Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇳🇱 NL

Who might be able to join this trial: - People over 18 years old who have undergone a PCI procedure (a procedure to open blocked heart arteries) for any reason, and whose details are recorded in the Netherlands Heart Registration database Who may not be able to join: - If a person has had more than one PCI procedure w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06567626 · University of Leicester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇬🇧 GB

**Who might be able to join this trial:** This trial has several different groups of participants. The criteria for each group are listed below. --- **Group 1 – Patients helping to design the decision support tool (co-design)** Who might be able to join this group: - Adults aged 18 or older who have personal experi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06572267 · Xijing Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with chronic coronary syndrome (a long-term heart condition involving reduced blood flow to the heart) - People who have at least one artery with a blockage of 50% or more in a vessel that is not the main one being treated, as measured by visua...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06573242 · Herlev and Gentofte Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
🇩🇰 DK

Who might be able to join this trial: - You must be over 18 years old - You must have been diagnosed with a type of heart failure where the heart is not pumping as strongly as it should (called heart failure with reduced ejection fraction, where the heart pumps less than 45% of its blood out with each beat) - Your hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06573892 · Nazarbayev University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 December 2024
🇰🇿 KZ

**Who might be able to join this trial:** - People who are 18 years of age or older - People who live in the city of Astana or the surrounding Akmola region - People who have been diagnosed with heart failure according to internationally recognised guidelines, classified as Class I–IV (NYHA scale) or Stage A–C (ACC/AHA...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06578234 · Region Skane Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇸🇪 SE

**Who might be able to join this trial:** *For patients being assessed for heart conditions:* - The person has agreed in writing to take part in the trial - The person has been referred to the Department of Clinical Physiology at Skåne University Hospital for a suspected or confirmed chronic coronary condition or hear...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06579807 · Instituto Nacional de Cardiologia de Laranjeiras Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇧🇷 BR

**Who might be able to join this trial:** - You are between 40 and 70 years old (any sex) and have been diagnosed with coronary artery disease (a condition affecting the heart's blood supply), such as a heart attack, unstable chest pain, or significant blockages found during a heart artery scan, and you are entering a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06580392 · Impulse Dynamics Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇮🇹 IT

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with heart failure that causes symptoms. - People whose heart is pumping at 40% or less of its normal capacity (a condition called heart failure with reduced ejection fraction), confirmed by a heart scan taken within the last 6 mont...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06585761 · Kafrelsheikh University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇪🇬 EG

Who might be able to join this trial: - People who are older than 18 years of age - People who have been diagnosed with heart failure that has been rated as moderate to severe in terms of how it affects daily activity (graded II–IV on a standard heart function scale) - People who are already taking standard heart failu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06586008 · Universitas Diponegoro Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2024
🇮🇩 ID

Who might be able to join this trial: - People who have been diagnosed with heart failure where the heart's pumping function is weakened (specifically, where less than 40% of blood is pumped out with each heartbeat). - People aged between 18 and 70 years old. Who may not be able to join: - People who have high blood p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06586424 · Universitas Diponegoro Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2024
🇮🇩 ID

Who might be able to join this trial: - Adults aged 18 to 70 years old who have been diagnosed with a severe type of heart attack (called STEMI) and have already had an emergency procedure to reopen the blocked heart artery (called primary PCI or PPCI). Who may not be able to join: - People who have a history of heart...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06587165 · Weill Medical College of Cornell University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - Babies between 30 days old and 1 year old who are scheduled for planned (non-emergency) heart surgery may be considered for this trial. - Babies in that age range who have a type of heart condition where the surgery is very likely to involve removing a small piece of heart muscle...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06588595 · University of Florida Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have had a procedure to open blocked heart arteries (called PCI) and are currently taking two blood-thinning medications together: low-dose aspirin (81mg once daily) plus either prasugrel (10mg once daily) or ticagrelor (90mg twice daily) - People whose PCI was don...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06593223 · The University of Hong Kong-Shenzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who are experiencing acute (sudden or severe) heart failure - People who have chronic (long-term) heart failure that has been stabilised and are being managed as outpatients - People who are willing to sign a consent form agreeing to take part in the study **Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06595147 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2026
🇨🇦 CA

Who might be able to join this trial: - People aged 60 years or older - People who have previously been diagnosed with early-stage breast cancer (stages I, II, or III) - People who finished their main cancer treatment at least one year ago, where that treatment included a type of chemotherapy called anthracyclines or a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06595992 · Second Affiliated Hospital, School of Medicine, Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2034
🇨🇳 CN

**Who might be able to join this trial:** - People who are at least 18 years old - People who are willing and able to give their informed consent to take part in the study - People who have been diagnosed with moderate aortic valve disease, confirmed by an ultrasound of the heart (echocardiogram) **Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06597019 · Novartis Pharmaceuticals Phase 3 · 23 countries Recruiting
Recruiting Phase 3 Est. completion 21 March 2028
🇦🇷 AR🇦🇹 AT🇧🇪 BE🇧🇷 BR🇨🇳 CN🇨🇿 CZ🇫🇷 FR🇩🇪 DE +15 more

Who might be able to join this trial: - Children aged 6 years old up to (but not including) 12 years old at the time of screening, of any sex - Children who have been diagnosed with a condition called heterozygous familial hypercholesterolemia (HeFH) — an inherited condition that causes high cholesterol — either throug...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06620653 · National University of Ireland, Galway, Ireland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇮🇪 IE

Who might be able to join this trial: - Adults aged 18 or older who have recently been in hospital. - People who have had their heart pumping strength (ejection fraction) measured and whose heart failure stage (NYHA Class) is known. - People with either a previously diagnosed or newly identified heart failure condition...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06623344 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇺🇸 US

**Who might be able to join this trial:** - Your heart's pumping function (called ejection fraction) is below 50%, meaning your heart is not pumping as efficiently as normal - You are willing to give your agreement to participate (informed consent) - You do not feel extreme discomfort in small, enclosed spaces (claustr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06625463 · Gadjah Mada University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 June 2025
🇮🇩 ID

**Who might be able to join this trial:** - People who have been diagnosed with acute coronary syndrome (a serious heart condition), were admitted to hospital for it, and have been home for at least 3 months but no longer than 1 year since being discharged - People aged between 18 and 65 years old - People who are exp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06630923 · Democritus University of Thrace Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2025
🇬🇷 GR

Who might be able to join this trial: - People who are 18 years of age or older - People who are experiencing a sudden worsening of chronic heart failure (CHF) - People who have signs of liver problems, shown through blood tests or a liver ultrasound - People who have a history of chronic heart failure and have previou...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06631157 · Fundación EPIC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
Hong Kong

Who might be able to join this trial: - People who are being treated with a product called Essential Pro as part of their normal hospital care, following the standard instructions for its use - People who have signed a form giving their informed consent to take part in the trial Who may not be able to join: - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06633159 · The League of Clinical Research, Russia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇷🇺 RU

**Who might be able to join this trial:** **Group 1 (Prospective – joining going forward):** - People who have been recommended to have a heart procedure to fix a leaky heart valve (called mitral regurgitation) using a specific device called the MitraClip G4 - People aged 18 years or older - People who understand and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06634121 · LMU Klinikum Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇩🇪 DE

Who might be able to join this trial: - People who are 18 years of age or older - People who have given written consent to participate - People whose Heart Team (a group of heart specialists) has recommended a procedure called M-TEER (a minimally invasive treatment for a heart valve problem) Who may not be able to joi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06645990 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2023
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older who were admitted to hospital for a serious heart condition called cardiogenic shock (when the heart cannot pump enough blood) between January 1, 2010, and December 31, 2023 - People who, during that admission, were supported by a heart-lung bypass mac...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06649305 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older, of any gender - People who have diabetes and need an OCT scan (a type of detailed imaging of blood vessels) or a procedure guided by OCT — including those diagnosed based on insulin or tablet use, abnormal fasting blood sugar, or other blood sugar te...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06655922 · Lin Zhao Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are older than 18 years of age - People who have at least one completely blocked coronary artery (a total blockage with no blood flow past the blockage) that has not yet been treated, where the blockage has been present for at least 3 months, and the affected bloo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06656832 · University of Leipzig Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇩🇪 DE

Who might be able to join this trial: - People who have been admitted to one of the participating hospitals with a sudden worsening of heart failure, shown by signs or symptoms of the condition - People whose heart scans or tests show structural (physical) changes to the heart, as defined by European Society of Cardiol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06657833 · Fundación EPIC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2027
🇪🇸 ES

**Who might be able to join this trial:** - You are over 18 years old and have been admitted to hospital with either stable heart disease or an urgent heart condition, and your doctors have decided you need a procedure to open a blocked or narrowed heart artery (called PCI). - During imaging inside your heart artery, d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06659393 · Novartis Pharmaceuticals Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
🇯🇵 JP

Who might be able to join this trial: - A parent or legally acceptable representative must provide written consent before treatment begins - Children aged 1 to under 18 years old who are starting Entresto for the first time to treat chronic heart failure Who may not be able to join: - Children who have previously take...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06662084 · University Hospital, Geneva Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇨🇭 CH

**Who might be able to join this trial:** - People (male or female) who have a severe form of cardiogenic shock (when the heart cannot pump enough blood) that has not responded to standard treatment, and who need a temporary machine to support their heart — either a device called VA-ECMO or a small pump device called...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06662890 · NHS National Waiting Times Centre Board Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2028
🇬🇧 GB

Who might be able to join this trial: - Adults aged 18 or older. - People who have had heart attack symptoms starting no more than 6 hours before treatment. - People who have had a specific type of heart attack called an acute anterior ST-segment elevation myocardial infarction (a serious heart attack affecting the fro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06673381 · Sohag University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2024
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with a serious heart condition called Acute Coronary Syndrome (ACS) and are not able to have a procedure called a primary PCI (a treatment used to open blocked heart arteries). Who may not be able to join: - People under 18 years o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06675552 · AstraZeneca Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇩🇪 DE

**Who might be able to join this trial:** - People who are 18 years of age or older at the time of signing the consent form - People who are currently admitted to a participating hospital and receiving full inpatient care, with a stay of at least 24 hours - People who have been diagnosed with a type of heart failure wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06676137 · Henan Institute of Cardiovascular Epidemiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 October 2028
🇨🇳 CN

Who might be able to join this trial: - People who experience angina symptoms (chest pain or discomfort that may be related to the heart) - People who have objective evidence of reduced blood flow to the heart muscle (confirmed through testing) - People whose coronary angiography (an X-ray imaging test of the heart's a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06678594 · Royal College of Surgeons, Ireland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 March 2026
🇮🇪 IE

**Who might be able to join this trial:** - People who have documented evidence of reduced blood flow to the heart muscle (confirm with trial site) - People who have at least one coronary artery with moderate to severe calcium buildup, confirmed by imaging, with a significant narrowing of the artery that is suitable f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06689111 · University Hospital of Patras Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇬🇷 GR

Who might be able to join this trial: - You are between 18 and 90 years old - You have heart failure with a weakened heart (pump function below 35%) and still have symptoms even though you are taking the best available medications - You have a specific abnormal heart electrical pattern called "complete left bundle bran...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06692751 · Centre Hospitalier Universitaire Dijon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇫🇷 FR

Who might be able to join this trial: - People who are being treated at Dijon University Hospital and have had a specific heart blood flow measurement (called IMR) taken during a coronary artery examination, as part of investigating chest pain or related symptoms without a clear blocked artery cause (a condition referr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06694727 · Tor Biering-Sørensen Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2028
🇩🇰 DK

Who might be able to join this trial: - Adults aged 18 years or older. - People who have a heart failure diagnosis recorded as a primary hospital discharge diagnosis in the Danish National Patient Registry, and who have had at least one dispensed prescription for two specific types of heart medications (a renin-angiote...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06697093 · Wroclaw Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇵🇱 PL

**Who might be able to join this trial:** - People aged 18 years or older - People who have cardiogenic shock (a condition where the heart cannot pump enough blood to meet the body's needs) of any cause, classified at a certain level of severity (SCAI stages B through E) - People whose blood pressure has been dangerous...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06698341 · National Heart Centre Singapore Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇸🇬 SG

Who might be able to join this trial: - People who are older than 21 years of age - People who are 50 years old or younger, regardless of whether they have cardiovascular risk factors (such as high blood pressure, high cholesterol, diabetes, obesity, or being a current smoker) at the time of their heart attack, OR peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06707662 · Parc de Salut Mar Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇪🇸 ES

Who might be able to join this trial: - People aged 18 years or older. - People whose heart pumping function is normal or only mildly reduced, confirmed by a heart ultrasound done within the last month (showing a pumping score above 40%). - People who need a pacemaker because their heart's electrical signal between the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06711666 · Institut National de la Santé Et de la Recherche Médicale, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇫🇷 FR

**Who might be able to join this trial:** **For the mother:** - Women who are at least 18 years old - Women who are currently pregnant - Women whose unborn baby has been diagnosed with a serious type of congenital heart disease (a heart condition present before birth that can affect how well the baby's blood carries o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06714409 · Oslo University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇳🇴 NO

Who might be able to join this trial: - People who are 18 years of age or older - People who have been admitted to the Cardiology ward at OUH Ullevål hospital with a diagnosis of acute decompensated heart failure (a sudden worsening of heart failure symptoms), as defined by the European Society of Cardiology - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06722521 · Asan Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2032
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 19 years or older - People who have no symptoms but have a significant buildup of calcium in the coronary arteries (a calcium score of 100 or higher), with no blockages that are causing blood flow problems — the calcium scan must have been done within the past 3...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06724653 · Chungnam National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 May 2025
🇰🇷 KR

**Who might be able to join this trial:** - People whose first heart ultrasound showed the heart pumping at less than 40% of its normal capacity (a measurement called ejection fraction) - People whose follow-up heart ultrasound showed the heart pumping at more than 50% of its normal capacity, with the heart's left cham...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06734065 · Linkoeping University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇸🇪 SE

Who might be able to join this trial: - People aged 18 or older (there is no upper age limit) - People who have been diagnosed with heart failure, regardless of how well their heart is pumping - People whose heart failure symptoms are classified as moderate to severe (NYHA Class III or IV), or those with milder symptom...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06736574 · Cytokinetics Phase 3 · 10 countries Recruiting
Recruiting Phase 3 Est. completion 1 September 2027
🇨🇦 CA🇨🇳 CN🇫🇷 FR🇩🇪 DE🇬🇷 GR🇮🇹 IT🇵🇱 PL🇪🇸 ES +2 more

**Who might be able to join this trial:** - People aged 18 to 85 years old at the time of signing the consent form - People who have had chronic heart failure with reduced pumping function and have been receiving treatment for it for at least 3 months before the screening visit - People who are regularly taking water...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06736665 · Spanish Society of Cardiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇪🇸 ES

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been found, using a special heart imaging technique called OCT, to have hardened, calcium-containing deposits (calcified nodules) in one of their heart arteries (not a previously stented section), where a procedure to open the artery...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06737679 · Centro Cardiologico Monzino Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 March 2025
🇮🇹 IT

Who might be able to join this trial: - People who have been diagnosed with heart failure - People who speak Italian - People who are willing to sign a consent form agreeing to take part in the trial Who may not be able to join: - People who have a documented cognitive impairment (such as memory or thinking difficulti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06738381 · Vestre Viken Hospital Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2026
🇳🇴 NO

**Who might be able to join this trial:** - People aged 18 or older who are willing and able to give informed consent and take part as required by the study guidelines - People who are currently in hospital due to a planned or unplanned heart or blood vessel disease event, or who have a known diagnosis of hardening or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06742567 · National Institute of Cardiovascular Diseases, Pakistan Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 November 2025
🇵🇰 PK

**Who might be able to join this trial:** - You are between 18 and 65 years old - You are currently having a type of heart attack called an "anterior STEMI" (a serious blockage in a specific artery at the front of the heart) - Tests show your heart's pumping strength is severely reduced (the heart is pumping less than...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06742931 · Samsung Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇰🇷 KR

**Who might be able to join this trial:** - People who are at least 19 years old. - People who are able to understand the risks, benefits, and alternatives involved, and are willing to sign a consent form. - People who have a stable, long-term heart condition (chronic coronary syndrome) and had a specific type of hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06744322 · Medical University Innsbruck Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇦🇹 AT🇩🇪 DE

Who might be able to join this trial: - People who have been diagnosed with an uncomplicated heart attack (either NSTEMI or STEMI type) according to current medical guidelines - People who are 18 years of age or older at the time of giving consent - People whose heart attack was treated with a procedure to open the blo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06745141 · Shanghai 10th People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with a type of heart attack called an ST-segment elevation myocardial infarction (STEMI) - People who have been assessed as having severe gum disease, which means having at least 5 teeth with significant loss of the tissue that attaches the gum...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06766006 · Maastricht University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇳🇱 NL

Who might be able to join this trial: - People who are receiving a type of heart and lung life support treatment called venoarterial extracorporeal life support (VA ECLS), which is a machine that helps the heart and lungs work when they are too weak to function on their own. Who may not be able to join: - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06767345 · Korea University Anam Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 25 January 2028
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 18 years or older. - People who have coronary artery disease (narrowing or blockage of the heart's arteries) and are having a procedure to open a blocked artery, where a special imaging device is used inside the artery during the procedure. - People who have at l...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06769256 · Henan Institute of Cardiovascular Epidemiology Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 75 years old - You are having a certain type of heart attack (called STEMI) and it started within the last 12 hours - During your heart procedure, blood flow in the blocked artery is still very limited or there is a large amount of clot present, even af...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06779552 · Abbott Medical Devices Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2032
🇺🇸 US

Who might be able to join this trial: - People who have had a CardioMEMS pressure sensor implanted in their heart (treatment group only) - People who are 18 years of age or older at the time of the sensor implant - People who have a history of a serious worsening of heart failure or fluid buildup related to heart failu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06779630 · Teleflex Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇦🇹 AT🇫🇷 FR🇩🇪 DE🇵🇱 PL🇨🇭 CH🇺🇸 US

Who might be able to join this trial: - People aged 18 or older - People who are able to understand the study and agree in writing to take part (at some sites outside the US, verbal consent may be accepted for people experiencing a certain type of heart attack) - People who are considered suitable candidates for a hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06783166 · Mansoura University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 July 2025
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 or older who are in hospital for acute heart failure with fluid buildup (congestion), shown by at least 2 signs such as swollen legs, fluid in the abdomen, shortness of breath when lying down, sudden breathlessness at night, recent weight gain of around 5 pounds, o...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06785168 · Kieu Nguyen Dang Phuong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇻🇳 VN

**Who might be able to join this trial:** - People who are 60 years of age or older - People who have been diagnosed with sarcopenia (low muscle mass and/or weakness) according to the 2019 Asian Working Group for Sarcopenia criteria — this means having low muscle mass measured by a bone density scan, AND either a weak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06791850 · West Virginia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

Who might be able to join this trial: - Adults between 50 and 80 years old who have been diagnosed by a doctor with advanced heart failure (a serious condition where the heart cannot pump enough blood, causing significant symptoms even at rest or with minimal activity) - Caregivers of patients with advanced heart failu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06792643 · IRCCS San Raffaele Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 29 October 2025
🇮🇹 IT

Who might be able to join this trial: - People aged 18 or older, of any sex - People who have had a heart attack leading to a state of dangerously low blood flow (called cardiogenic shock or cardiac arrest), who are undergoing a procedure to open blocked heart arteries (called PCI, with or without a stent), and who nee...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06793670 · Università Vita-Salute San Raffaele Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2027
🇮🇹 IT

**Who might be able to join this trial:** - People who are over 18 years old - People who are scheduled for planned (non-emergency) mitral heart valve repair or replacement surgery using a heart-lung bypass machine, through either a chest incision down the middle or a smaller side incision - People whose heart scans be...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06800430 · University of Edinburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 March 2027
🇬🇧 GB

Who might be able to join this trial: **Group 1 – People having heart bypass surgery:** - Men and women aged 18 or older - People having coronary artery bypass graft (CABG) surgery for blockages in multiple heart arteries, where at least one vein from the leg (called a saphenous vein) is used as a bypass graft **Grou...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06804499 · Tampere Heart Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇫🇮 FI

Who might be able to join this trial: - People who are older than 18 years of age. - People who live in the Wellbeing Services County of Pirkanmaa area and are seeking treatment for coronary artery disease (a condition affecting the arteries that supply blood to the heart). - People whose coronary artery disease has be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06809686 · Richmond Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 January 2027
🇬🇧 GB

Who might be able to join this trial: - People who are between 45 and 80 years old (inclusive) at the time of signing the consent form - People who have been diagnosed with heart failure - People who are willing and able to give their informed consent to take part in the study Who may not be able to join: - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06819618 · University Medical Center Goettingen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2025
🇩🇪 DE

Who might be able to join this trial: - People who are 18 years of age or older - People who have a type of heart failure where the heart muscle is weakened and pumps less blood than normal (with a specific heart pumping measurement below 41%) - People who are currently in hospital for worsening heart failure, have a s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06820970 · Henan Institute of Cardiovascular Epidemiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with coronary heart disease where full restoration of blood flow to the heart was not completed, based on imaging showing at least one significantly blocked artery (confirm with trial site for specific measu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06823583 · Bryan Heart Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are scheduled to have a VAD (ventricular assist device, a mechanical heart pump) implanted - People who speak English, as the tool being studied has not yet been translated into other languages - People who are 19 years of age or older at the time of the implant, a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06827314 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇮🇹 IT

Who might be able to join this trial: - Adults aged 18 or older who are admitted to a participating cardiac intensive care unit with suspected cardiogenic shock (a serious condition where the heart cannot pump enough blood) classified as a moderate to severe stage (stages C through E on a standard medical scale). - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06828770 · Renata Medical Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

Who might be able to join this trial: - A legally authorised representative of the patient has been told about the device treatment, agrees to its terms, and has signed a written consent form - The patient's condition has been assessed as appropriate for treatment with the Minima Stent System according to the device's...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06829160 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - People aged 18 and over - People who have been diagnosed with Ischemia with Non-Obstructive Coronary Arteries (INOCA) — a heart condition where there are signs of reduced blood flow to the heart, but the main heart arteries are not significantly blocked — confirmed through a CT s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06831409 · HeartFlow, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are retired NFL (National Football League) players Who may not be able to join: - People whose heart CT scan images could not be successfully processed by the computer systems used in this trial to analyse blood flow and plaque in the arteries (confirm with trial site...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06832722 · 4TEEN4 Pharmaceuticals GmbH Phase 2 · 7 countries Recruiting
Recruiting Phase 2 Est. completion 30 December 2026
Armenia🇧🇪 BE🇨🇿 CZ🇫🇷 FR🇳🇱 NL🇵🇱 PL🇷🇸 RS

**Who might be able to join this trial:** - People who have signed an informed consent form agreeing to take part in the study. - People diagnosed with cardiogenic shock (a serious condition where the heart cannot pump enough blood), confirmed by needing medications to keep blood pressure up, having elevated levels of...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06844006 · Medisch Spectrum Twente Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇳🇱 NL

Who might be able to join this trial: - People who have been diagnosed with heart failure (any type). - People who are over 18 years old. Who may not be able to join: - People who do not understand the Dutch language. - People who have allergies that would prevent medication doses from being safely increased. - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06844032 · National Medical Research Center for Cardiology, Ministry of Health of... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇷🇺 RU

**Who might be able to join this trial:** - You have signed and dated a consent form agreeing to take part in the study - You have been diagnosed with heart failure that causes symptoms during moderate or minimal physical activity (classified as NYHA class II or III) - Your heart's pumping function is relatively preser...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06849752 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 40 years old or older at the time of joining - You are willing to read and sign a consent form agreeing to take part - Your activity level and breathlessness symptoms fall within a moderate-to-severe range based on a standard questionnaire (confirm with trial site) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06851949 · Cardiac Success Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 January 2026
🇮🇱 IL

Who might be able to join this trial: - Adults aged 18 or older - People whose left ventricle (the heart's main pumping chamber) is enlarged, measuring 55mm or more at its most relaxed point - People whose heart is pumping between 20% and 40% of its capacity (known as ejection fraction) - People with mild or no leaking...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06863545 · Second Affiliated Hospital, School of Medicine, Zhejiang University Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 April 2030
🇨🇳 CN🇰🇷 KR

Who might be able to join this trial: - People aged 18 or older. - People who have at least one artery with a significant plaque buildup, identified by a special heart scan called a CCTA, where the artery is either narrowed by 50% or more, or where plaque takes up 70% or more of the artery wall. - People whose plaque s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06872645 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

**Who might be able to join this trial:** - People with end-stage kidney failure who are currently on peritoneal dialysis (a type of home dialysis that uses the abdomen) with a working dialysis catheter - People whose top blood pressure reading is above 130 mmHg - People whose blood sodium level is above 135 mmol/L (b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06874556 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - Adults who have been admitted to hospital with worsening heart failure and who may be ready to go home early with the support of a care programme and regular monitoring. - People with suddenly worsening heart failure who are at home or being seen in an outpatient clinic and need...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06877195 · Cardiochirurgia E.H. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇮🇹 IT

Who might be able to join this trial: - People undergoing either combined or isolated surgical interventions (confirm with trial site) - People whose veins are of a suitable size for the procedure - People whose graft blood flow measurements meet the required levels Who may not be able to join: - People whose veins an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06880575 · Beijing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇨🇳 CN

Who might be able to join this trial: - People who are 75 years of age or older. - People who were admitted to hospital due to chest pain (angina) or other symptoms related to coronary heart disease. - People who have been diagnosed with coronary heart disease, confirmed by at least one of the following: a coronary ang...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06884631 · Centro Cardiologico Monzino Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇮🇹 IT

Who might be able to join this trial: - Adults over 18 years old who have been diagnosed with heart failure, either in the past or currently, with symptoms ranging from mild to moderate (the heart is not pumping as well as it should, but the person is still able to do some daily activities) - People whose heart's main...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06885164 · Aalborg University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇩🇰 DK

Who might be able to join this trial: - People aged 18 to 90 years old - People with heart failure symptoms classified as NYHA Class II or higher, meaning the heart condition causes at least some limitation during physical activity (confirm with trial site) Who may not be able to join: - People who are pregnant - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06887413 · Ceric Sàrl Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇮🇹 IT

**Who might be able to join this trial:** - Adults between 19 and 74 years old - People experiencing a specific type of heart attack (called an anterior STEMI) showing significant changes on a heart tracing (ECG) in the front-wall leads, with abnormal heart wall movement confirmed by imaging - People where the blockag...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06891456 · Pasquale Santangeli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older - People who have coronary artery (heart) disease and have previously had a heart attack - People whose heart's pumping strength (called ejection fraction) is at least 20%, confirmed by an ultrasound of the heart done within the past 90 days - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06895070 · XVIVO Perfusion Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇺🇸 US

**Who might be able to join this trial:** **For the person receiving the heart transplant (recipient):** - Adults aged 18 or older. - People who have signed a consent form agreeing to take part in the study. - People who are already on the waiting list for a heart transplant. **For the donor heart:** - Donor hearts w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06896227 · Heinrich-Heine University, Duesseldorf Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇩🇪 DE

**Who might be able to join this trial:** - People who have had their aortic heart valve replaced using a catheter-based procedure (called TAVR) where the catheter was inserted through an artery in the groin (transfemoral approach). **Who may not be able to join:** - People whose TAVR procedure used an access point ot...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06896903 · Baylor Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older - People who are being assessed for a condition involving chest pain caused by problems with how the heart's blood vessels function (rather than blockages) — known as ANOCA or INOCA - People who have symptoms that suggest they may be experiencing angin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06898515 · Reprieve Cardiovascular, Inc Phase 3 · 5 countries Recruiting
Recruiting Phase 3 Est. completion 1 August 2027
🇩🇪 DE🇮🇹 IT🇵🇱 PL🇪🇸 ES🇺🇸 US

**Who might be able to join this trial:** - People who have been admitted to hospital with heart failure for more than 24 hours, with new or worsening symptoms and signs confirmed by physical examination, lab results, or monitoring, and who are receiving or planned to receive heart failure treatment. - People who are...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06900270 · University of Sao Paulo General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇧🇷 BR

Who might be able to join this trial: - People who have no history of heart disease, chest pain, heart attack, heart procedures, stroke, or circulation problems in the legs or other vessels (Group I) - People who have been found to have minor, non-blocking plaque or narrowing in the heart's arteries (less than 50% bloc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06905405 · Sheffield Teaching Hospitals NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
🇬🇧 GB

Who might be able to join this trial: - Adults aged 18 years or older, either male or female. - People who experience shortness of breath when physically active or exerting themselves. - People with a blood test result showing a heart stress marker called NTproBNP above 400 ng/L, measured while the heart is in a normal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06911294 · Catholic University of the Sacred Heart Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 February 2026
🇮🇹 IT

Who might be able to join this trial: - People aged between 40 and 69 years old. - People whose 10-year heart and blood vessel disease risk score (called SCORE2) falls between 2.5% and 10% (confirm with trial site on how this is calculated). - People diagnosed with metabolic syndrome, meaning they have three or more of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06915597 · Kutahya Health Sciences University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Adults aged 18 or older who have coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked) - People who are having a procedure called PCI (a procedure to open blocked or narrowed heart arteries) where a special balloon coated wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06920927 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇨🇦 CA

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with chronic kidney disease - People who have coronary artery disease, either a type called non-ST elevation acute coronary syndrome (a certain kind of heart attack or chest pain episode) or ongoing symptoms of stable...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06923267 · Centre Hospitalier Régional d'Orléans Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 April 2027
🇫🇷 FR

Who might be able to join this trial: - People who are on a breathing machine (mechanical ventilator) through a tube in their airway, have been on it for at least 24 hours, and are being prepared for a test to see if they can breathe on their own - People whose level of alertness and calmness falls within a specific ra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06932081 · Leiden University Medical Center Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇩🇪 DE🇳🇱 NL North Macedonia🇬🇧 GB🇺🇸 US

Who might be able to join this trial: - People who were born with a heart defect (a structural problem with the heart present from birth) - People who are 18 years of age or older - People who have been started on a type of medication called an SGLT2 inhibitor (a drug commonly used for heart or kidney conditions, or di...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06934798 · University of Sao Paulo Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 July 2025
🇧🇷 BR

Who might be able to join this trial: - People aged 18 or older. - People who have had heart bypass surgery, heart valve surgery, or both, and who develop a condition called vasoplegic syndrome within the first 24 hours after the operation — this means their blood pressure drops too low and does not improve after recei...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06935370 · Boehringer Ingelheim Phase 3 · 29 countries Recruiting
Recruiting Phase 3 Est. completion 4 February 2029
🇦🇷 AR🇧🇪 BE🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇱 CL🇨🇳 CN🇨🇴 CO +21 more

**Who might be able to join this trial:** - People who are at least 18 years old (or the legal age of consent in their country, if older than 18) - People who are willing and able to sign a formal consent form before the trial begins - Men or women — though women who could become pregnant must be willing and able to u...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06937827 · Hackensack Meridian Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 April 2027
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 90 years old who were discharged from Ocean University Medical Center (OUMC) - People who were admitted to hospital for a flare-up of a type of heart failure called heart failure with preserved ejection fraction (HFpEF) - People who were sent home after thei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06939751 · Inova Health Care Services Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2031
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older at the time of joining the trial - People who have received a heart transplant within the past month (within a window of roughly 2 weeks either side) - People whose follow-up care is planned to continue at the transplant centre for at least one year - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06951308 · Damascus University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
Syria

**Who might be able to join this trial:** - People with type 2 diabetes who are having coronary artery bypass surgery using a heart-lung bypass machine, with no other heart procedures performed at the same time. **Who may not be able to join:** - People whose medical records have missing information. - People whose su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06964685 · Abiomed Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have had a heart attack that started less than 36 hours before arriving at the cardiac catheterisation lab, confirmed by heart tracing (ECG) and/or blood tests showing a specific type of heart attack (STEMI, STEMI equivalent, new left bundle branch block, or NSTEM...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06965023 · Azienda Ospedaliera "Sant'Andrea" Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇮🇹 IT

Who might be able to join this trial: - Adults over 18 years of age - People who have had a certain type of heart attack (called STEMI) and are being sent for an urgent procedure to look at the heart's arteries - People whose heart artery is found to be completely or almost completely blocked by a blood clot during tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06967194 · Tel-Aviv Sourasky Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇮🇱 IL

Who might be able to join this trial: - People who have been diagnosed with a specific type of heart attack called an ST-segment elevation myocardial infarction (STEMI), confirmed by heart tracing (ECG), symptoms, and a heart artery procedure. - People who, after their heart artery procedure, are classified as a specif...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06967441 · Minjae Yoon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇰🇷 KR

Who might be able to join this trial: - Adults aged 19 years or older who have been admitted to a cardiology ward with acute heart failure - People whose blood test shows a protein called NT-proBNP above 300 pg/mL, which is a marker of heart stress - People where the treating doctor suspects a possible respiratory vira...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06969547 · Tomsk National Research Medical Center of the Russian Academy of Scien... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 May 2025
🇷🇺 RU

Who might be able to join this trial: - People who have a condition called INOCA, where the heart is not getting enough blood flow but the main heart arteries do not appear blocked - People who have been diagnosed with blocked or narrowed coronary arteries (the blood vessels that supply the heart) - People who have no...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06969560 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

Who might be able to join this trial: - Children and teenagers between 8 and 18 years old who are being seen as outpatients (not currently admitted to hospital) at the time of joining the study. - People with a chest measurement of at least 69.85 cm around the chest, measured just below the chest muscles. - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06969924 · Leiden University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇳🇱 NL

**Who might be able to join this trial:** - People with adult congenital heart disease (a heart condition present from birth) who have had a CRT device implanted (a type of pacemaker that helps the heart beat more efficiently) **Who may not be able to join:** - People who were under 18 years old at the time their CRT...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06972225 · Olivier F. Bertrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2035
🇨🇦 CA

Who might be able to join this trial: - Adults aged 18 years or older - People who had a coronary angioplasty procedure using a drug-eluting balloon (a special balloon used to open blocked heart arteries that also delivers medication) at some point between January 2010 and December 2025 - People whose procedure details...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06973902 · Quovadis Associazione Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇮🇹 IT

**Who might be able to join this trial:** - Adults aged 18 or older of any sex - People who are able to understand and sign a consent form agreeing to take part in the study and to allow their personal health data to be used - People living with heart failure that is still causing symptoms despite already receiving th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06977295 · Instituto de Investigación Biomédica de Salamanca Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇫🇷 FR🇳🇱 NL🇪🇸 ES

Who might be able to join this trial: - People aged 18 years or older - People who had a special type of heart CT scan (called a coronary computed tomography angiography, or CCTA) to check for or assess coronary artery disease between 2019 and 2024 - People who also had at least one other heart test or recorded health...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06994221 · RenJi Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇨🇳 CN

Who might be able to join this trial: - People between 18 and 75 years of age. - People who have been diagnosed with a heart attack classified as either STEMI or NSTEMI, according to standard cardiology guidelines. - The trial aims to enrol an equal number of male and female participants. - People who have undergone a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06995183 · E.S.stroes Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇳🇱 NL

**Who might be able to join this trial:** **Elevated Lp(a) group:** - Men or women aged 50 or older - People with an Lp(a) blood level of 150 nmol/L or higher - People who were identified through a family screening programme for high Lp(a) levels at the Amsterdam UMC Vascular Medicine outpatient clinic - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06995495 · RenJi Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇨🇳 CN

Who might be able to join this trial: - You are between 18 and 75 years old - You have been diagnosed with a heart attack (either a STEMI or NSTEMI type, as confirmed by standard medical guidelines) - The trial is looking to include roughly equal numbers of men and women - You have had or will have a procedure to look...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07001007 · HJN Sverige AB/Neko Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇸🇪 SE

Who might be able to join this trial: - You must already be taking part in the main SCAPIS 2 study at Danderyd Hospital in Stockholm, Sweden - You must have already had a heart ultrasound (echocardiography) examination as part of that study Who may not be able to join: - People who are not able to give their own conse...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07002164 · Chonnam National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2030
🇰🇷 KR

**Who might be able to join this trial:** - You are 19 years of age or older - You have had a type of heart attack that doctors call a "non-ST-elevation myocardial infarction" (confirm with trial site if unsure which type you had) - You have new or worsening shortness of breath that is affecting your daily activities -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07013344 · IRCCS Ospedale San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 June 2025
🇮🇹 IT

Who might be able to join this trial: - People who have been referred for a planned (non-emergency) heart artery imaging procedure (coronary angiography) because their doctor suspects they may have blocked or narrowed heart arteries. - People who have had a specific blood test called NT-proBNP taken during their hospit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07013591 · Brigham and Women's Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are scheduled to have planned (non-emergency) coronary artery bypass graft (CABG) heart surgery using a heart-lung bypass machine - People who have at least one factor that puts them at higher risk of complications after s...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07016477 · Semmelweis University Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 30 May 2029
🇩🇪 DE🇭🇺 HU🇳🇱 NL🇨🇭 CH🇺🇸 US

Who might be able to join this trial: - People for whom a transcatheter aortic valve implantation (a minimally invasive heart valve procedure) has been recommended by their doctor - People for whom both a CT scan and an invasive coronary angiography (a procedure to look at the heart's arteries) have been recommended as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07020702 · University Hospital, Bordeaux Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 September 2030
🇫🇷 FR

**Who might be able to join this trial:** - People who have a weakened heart muscle (cardiomyopathy) where the heart is pumping at a moderate level (between 35% and 50% efficiency) and who also have at least one additional heart-related risk factor (confirm with trial site for which risk factors apply) - People who hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07022067 · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇮🇹 IT

Who might be able to join this trial: - People who have been diagnosed with chronic coronary syndrome (a long-term heart condition) according to specific heart health guidelines. - People who are over 18 years of age. - People who have been admitted to hospital, or who had access to emergency care, at least once in the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07023536 · University of Salerno Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇮🇹 IT

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with chronic heart failure for at least 6 months, and whose treatment has been stable for at least 1 month - People whose heart failure falls into a moderate severity category, classified by doctors as NYHA functional c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07023679 · The Second Hospital of Anhui Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 June 2029
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older, of any sex - People who have had a type of heart attack called a STEMI (where specific changes are seen on a heart tracing test called an ECG), and who are planned to have a procedure to open a blocked heart artery - People whose heart attack chest pa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07034157 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2026
🇨🇳 CN

Who might be able to join this trial: - Adults aged 18 years or older - People with coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked) who are scheduled to have a planned, non-emergency procedure called PCI (a procedure to open blocked heart arteries, sometimes calle...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07035106 · Ludwig Boltzmann Gesellschaft Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2026
🇦🇹 AT

Who might be able to join this trial: - People who were between 18 and 65 years old at the time they were admitted to an intensive care unit (ICU) - People who stayed in the ICU for at least 48 hours - People who have been discharged from the ICU within the last 2 years - People who have been diagnosed with diabetes an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07035171 · Rigshospitalet, Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 18 June 2026
🇩🇰 DK

Who might be able to join this trial: - People who are scheduled to have planned, non-emergency heart bypass surgery (CABG) for the first time, with no other heart procedures planned at the same time - People who are 18 years of age or older - People whose surgery is at least two weeks away at the time of joining - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07036770 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇧🇪 BE

**Who might be able to join this trial:** - People who have given their written agreement to take part, before any screening begins (or whose legal representative has done so on their behalf) - People who are at least 18 years old at the time of signing the consent form - People who have been assessed by a doctor as ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07038356 · Christian Schulze Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 April 2026
🇩🇪 DE

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with a sudden worsening of heart failure, based on a doctor's assessment, and are already taking a type of medication called an SGLT2 inhibitor - People with elevated levels of certain heart stress markers in their blood (BNP or NTp...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07038408 · Ceric Sàrl Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2028
🇪🇪 EE

**Who might be able to join this trial:** - Adults aged 18 to 68 years old - People who have blockages in one or more heart arteries that are new (not previously treated), low to moderately complex, up to 30mm long, and in arteries of a certain size range (2.75–4.0mm wide) - People with no more than 3 blocked areas in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07045194 · Orchestra BioMed, Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have a narrowing (blockage) that has come back inside a previously placed stent (called in-stent restenosis) in a heart artery, where one or two stent layers are present. - The affected artery must be of a certain size — not too small and not too large (between 2....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07055152 · University of Pisa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇮🇹 IT

**Who might be able to join this trial:** - You must be over 18 years old. - You may be eligible if you have been diagnosed with a heart attack where the coronary arteries were found to be mostly clear (not blocked), confirmed by a special X-ray procedure of the heart's arteries. - You may be eligible if you have been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07058857 · Universitas Diponegoro Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇮🇩 ID

Who might be able to join this trial: - People who have had a specific type of heart attack (called a STEMI) that started less than 12 hours ago - People who have agreed to take part in the study - People whose heart attack is not causing severe heart pump failure at the time they arrive for care (Killip class I or II...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07060937 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇵🇰 PK

**Who might be able to join this trial:** - People who are between 30 and 50 years old - People who have had heart bypass surgery (called CABG) - Both men and women are eligible - People who are able to move around (mobile) after their surgery - People who are on day 3 or day 5 of recovery after their bypass surgery *...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07062744 · Bach Mai Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇻🇳 VN

**Who might be able to join this trial:** - You are 18 years of age or older. - You have signed a written agreement confirming you understand and agree to take part in the study. - You have been diagnosed with a serious heart condition called cardiogenic shock (when the heart suddenly cannot pump enough blood) caused b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07063147 · Tianjin Chest Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇨🇳 CN

Who might be able to join this trial: - People who have symptoms related to a condition called stable chest pain (SCP), where a blockage in the heart's arteries is suspected as the cause - People who have been referred for a type of heart ultrasound test (called a TTE) to investigate their chest pain - People who are 1...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07077057 · Cardiocentro Ticino Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇨🇭 CH

**Who might be able to join this trial:** - People who are experiencing symptoms that could suggest a possible heart attack, such as chest pain, shortness of breath, sweating, nausea or vomiting, pain spreading to the shoulder, arm, jaw, or back, unusual tiredness, or feeling lightheaded - People who are 18 years of ag...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07079735 · Columbia University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 17 January 2028
🇺🇸 US

Who might be able to join this trial: - Adults older than 18 years who have received a heart transplant and have not yet started a CMV (cytomegalovirus) prevention medication program. Who may not be able to join: - People who have had, or are suspected to have had, a CMV (cytomegalovirus) infection or illness within t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07083011 · Mayo Clinic Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2027
🇺🇸 US

**Who might be able to join this trial:** This trial has three separate groups. Please read the group that may apply to you: **Group 1 – Heart Failure with Preserved Ejection Fraction (HFpEF):** - You are 30 years of age or older and experience shortness of breath during physical activity - Your heart is pumping norm...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07087431 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2026
🇺🇸 US

Who might be able to join this trial: - People between the ages of 30 and 75 years old - People who have an established relationship with a primary care provider within the Mass General Brigham health system, with at least one visit in the past 2 years Who may not be able to join: - People who are currently taking med...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07091682 · Biotronik AG Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇩🇪 DE🇭🇺 HU🇮🇹 IT🇱🇻 LV🇵🇱 PL🇪🇸 ES🇨🇭 CH

**Who might be able to join this trial:** - People aged 18 to 80 years old - People who have given written consent to take part before any study-related procedures begin - People whose condition means a heart procedure (called PCI — where a blocked artery is opened using a small tube and balloon) is considered appropr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07093528 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are already enrolled in a related study called the CS-reducer HFPEF study (IRB# 25-002292) Who may not be able to join: - People who have metal implants in their body that are not safe for MRI scans - People who are unable or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07094737 · Fondazione Don Carlo Gnocchi ETS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇮🇹 IT

Who might be able to join this trial: - People who have coronary artery disease (a condition affecting the heart's blood vessels) and/or heart failure, and whose doctors have determined they meet the current medical standards for being sent to a cardiac rehabilitation program - People attending either an inpatient card...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07096544 · Baylor Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - People between the ages of 21 and 85 - People who have had a HeartMate III Left Ventricular Assist Device (a mechanical heart pump) implanted - People whose heart pump device is working normally, based on device readings - People who are medically stable and ready to be disc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07096973 · Hochgebirgsklinik Davos Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 August 2035
🇨🇭 CH

Who might be able to join this trial: - People who are taking part in cardiac rehabilitation at the HGK (a specific rehabilitation centre) - People who are aged 18 or older - People who have given written agreement to take part in the study Who may not be able to join: - People who do not have enough knowledge of Germ...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07100561 · Komfo Anokye Teaching Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
Ghana

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with heart failure - People whose heart failure has been classified by a doctor as NYHA Class II, III, or IV (a medical scale used to describe how much heart failure affects daily activity — confirm with trial site fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07107568 · Medical University Innsbruck Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇦🇹 AT

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with severe narrowing of the aortic heart valve and whose doctors have determined that a procedure is needed, based on current European heart guidelines - People who have been assessed as suitable candidates...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07109752 · Tung Wah College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2026
Hong Kong

Who might be able to join this trial: - People who have been diagnosed with coronary heart disease (a condition affecting the blood vessels of the heart) within the past 6 months - People who have already received treatment such as a procedure to open blocked arteries (called PCI) and/or heart medications - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07113223 · Idoven 1903 S.L. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇪🇸 ES🇸🇪 SE

Who might be able to join this trial: **Group S – People with possible heart failure symptoms:** - People aged 65 or older - People who are experiencing symptoms that may suggest heart failure, such as shortness of breath (during activity, at rest, when lying down, or waking at night struggling to breathe), tiredness,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07114393 · Cathreine BV Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇳🇱 NL

**Who might be able to join this trial:** - Adults aged 18 or older who have had a procedure to open blocked or narrowed heart arteries (called PCI) and whose case has been recorded in the Netherlands Heart Registration (NHR) quality database. - People whose artery blockage meets at least one of the following "complex...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07131631 · Minneapolis Heart Institute Foundation Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇮🇹 IT🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who have heart failure where the heart's pumping function is weakened (specifically, the heart pumps out less than 50% of its blood with each beat, as measured by an ultrasound of the heart), and who have a leaky mitral valve (a valve in the heart) that is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07133984 · Weill Medical College of Cornell University Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇦🇹 AT🇨🇦 CA🇨🇳 CN🇷🇸 RS🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older, both men and women - People whose heart pumps at a reduced capacity (specifically, the heart's pumping strength is 40% or less), confirmed by a heart scan done within the past 2 months - People who have significant blockages in multiple important hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07137936 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2036
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 80 years old - People who have had a heart attack and have since had a specific heart scan (called a cardiac MRI) at Anzhen Hospital at least one month after the heart attack, during a stable period of recovery **Who may not be able to join:** - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07154186 · Sohag University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇪🇬 EG

**Who might be able to join this trial:** - People who are 18 years of age or older - People of any sex - People who do not have diabetes — meaning no history of diabetes, a blood sugar control marker (HbA1c) below 6.5%, and a fasting blood sugar level below 126 mg/dL - People who have been confirmed to have coronary a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07160491 · Shenyang Northern Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2029
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 80 years old - People who have had chest pain lasting more than 30 minutes, starting within the last 12 hours - People whose heart tracing (ECG) shows a specific pattern of abnormal electrical activity across two or more connected areas of the heart, indicat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07163858 · Infirmerie Protestante de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇫🇷 FR

Who might be able to join this trial: - Adults who need coronary bypass heart surgery (surgery to improve blood flow to the heart) - People having the surgery either as a planned procedure or as a medical emergency - People who have not had any previous heart surgery - People whose heart is pumping at a certain minimum...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07167368 · Haiyan Pan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇨🇳 CN

Who might be able to join this trial: - People who have a stable, long-term form of heart failure where the heart's pumping function is reduced, along with reduced kidney function (as measured by a specific kidney test result below a certain level) - People whose heart failure symptoms are moderate — meaning they have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07169201 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇨🇳 CN

Who might be able to join this trial: - Adults aged 18 or older who have suspected or confirmed coronary artery disease (a condition affecting the heart's blood vessels), or who have type 2 diabetes Who may not be able to join: - People who are unable to undergo CT angiography or angiography (special imaging tests tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07181512 · Yifan Guo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 April 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 years or older - People who have had both a standard chest CT scan (without contrast dye) and a coronary CT angiography (a detailed heart scan using contrast dye) within the past 30 days - People whose coronary arteries (the blood vessels around the heart) are clea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07184541 · Lee Anne Siegmund Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 55 years or older - People who have been diagnosed with heart failure, whether recently or some time ago - People who are currently in hospital receiving treatment for heart failure symptoms, such as water tablets given through a drip, being asked to limit fluid intak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07185100 · German Heart Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇩🇪 DE

Who might be able to join this trial: - People who have been diagnosed with diabetes, are taking diabetes medication, or have had a blood test showing high blood sugar levels (HbA1c) - People who have been diagnosed with chronic kidney disease, or whose blood tests suggest kidney function problems at a moderate or more...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07192211 · Rohto Pharmaceutical Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 September 2028
🇯🇵 JP

Who might be able to join this trial: - People who have been diagnosed with long-term heart failure caused by reduced blood flow to the heart, and who are scheduled to have open-heart bypass surgery (a procedure to reroute blood around blocked arteries) - People whose heart pumping strength, measured by a heart ultraso...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07195149 · Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp... Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 April 2030
🇵🇱 PL

**Who might be able to join this trial:** - You are older than 18 years of age. - You have stable coronary artery disease (a long-term, non-emergency heart condition) and are scheduled for bypass heart surgery (CABG) with at least 2 bypass grafts planned. - Your blocked heart arteries have been confirmed by specific h...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07199088 · University of Health Sciences Lahore Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 October 2026
🇵🇰 PK

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed with Acute Decompensated Heart Failure (a sudden worsening of heart failure), regardless of which type they have - People who show at least one sign of fluid build-up in the body, such as fluid around the lungs (...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07202000 · Massachusetts General Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - People who are 40 years of age or older - People with a body mass index (a measure of body weight relative to height) of 27 or above - People whose heart is pumping at least 50% of its normal capacity, and who experience mild to moderate heart failure symptoms such as shortness o...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07202754 · Istanbul Mehmet Akif Ersoy Educational and Training Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 July 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People who have been diagnosed with complex coronary artery disease (a condition affecting the heart's blood vessels) - People between the ages of 18 and 85 years old **Who may not be able to join:** - People who have been diagnosed with cardiogenic shock (a serious conditio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07205341 · HemoCept Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - The person joining (or their legal representative) must have agreed to take part by signing a consent form before any study procedures begin. - Participants must be between 18 and 80 years old (inclusive), of any gender. - Participants must be receiving care at one of the healthc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07206602 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People whose heart's pumping strength (measured as Left Ventricular Ejection Fraction, or LVEF) was below 50% within the last 6 months - People whose heart's electrical signal duration (called QRS duration) is 130 milliseconds or longer o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07209098 · Impulse Dynamics Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2030
🇺🇸 US

Who might be able to join this trial: - People who have been continuously recorded in the relevant database for at least one year before the study start date - People aged 18 or older, who would be placed in either the treatment group or the comparison group - People who have been diagnosed with a moderate-to-severe le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07217392 · Abbott Medical Devices Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇧🇷 BR🇫🇷 FR🇩🇪 DE🇮🇳 IN🇲🇾 MY🇸🇬 SG🇪🇸 ES

Who might be able to join this trial: - People who meet current medical guidelines for receiving one of two specific heart leads (Tendril STS 2088TC or UltiPace LPA1231) placed in a particular area of the heart called the Left Bundle Branch Area (confirm with trial site). - People who are 18 years of age or older, or w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07219511 · Vasa Therapeutics Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 or older at the time of signing the consent form - People who have been diagnosed with a type of heart failure called HFpEF, based on recognised medical guidelines - People whose heart failure symptoms fall into a moderate category known as NYHA Class II or II...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07225842 · University of Florida Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are already receiving a specific blood-thinning medication called cangrelor, given through a drip at a standard dose, for at least two hours as part of their usual medical care - People aged 18 years or older - People who are willing and able to sign a written cons...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07230847 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older - Men, or women who are not pregnant - People who have had an acute coronary syndrome (a sudden, serious heart condition such as a heart attack) and need a procedure called PCI, which opens blocked heart arteries using a small balloon and often a sten...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07231939 · Collegium Medicum w Bydgoszczy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇵🇱 PL

Who might be able to join this trial: - People who had a heart procedure (either a coronary angiography, which is an X-ray of the heart's blood vessels, or a PCI, which is a procedure to open blocked heart arteries) during the study period, and for whom all the necessary medical information and measurements are availab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07235462 · Bayer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2028
🇩🇪 DE

**Who might be able to join this trial:** - You must be 18 years old or older at the time you sign the consent form - You must have been diagnosed with ATTR-CM (a heart condition caused by a protein called transthyretin), either the wild-type (age-related) or hereditary (inherited gene variant) form - You must have sig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07237451 · Grigore T. Popa University of Medicine and Pharmacy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇷🇴 RO

Who might be able to join this trial: - Adults aged 18 years or older - People whose heart is pumping at a rate measured above 40% (known as ejection fraction) - People with moderate-to-severe chronic kidney disease (a kidney function score between 15 and 60 on a standard measurement scale), whether or not they have di...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07238920 · Shenyang Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults over 18 years old, of any sex, who are right-handed and have a resting heart rate between 60 and 100 beats per minute. - People with a confirmed diagnosis of coronary heart disease (CHD), meaning at least one of the following applies: an abnormal stress test result; a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07245069 · University Medical Centre Ljubljana Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2028
🇸🇮 SI

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with breast cancer (confirmed through a tissue sample) and are planned to receive a specific type of chemotherapy before or after surgery, involving 4 cycles of either epirubicin + cyclophosphamide or doxorubicin + cyc...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07252830 · Elsan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2025
🇫🇷 FR

**Who might be able to join this trial:** - People who are between 41 and 79 years old and have been referred to a general heart specialist (cardiologist) - People whose LDL cholesterol (often called "bad cholesterol") level is above 1.6 g/L, or above 1.3 g/L if they also have at least one major heart risk factor such...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07252856 · Fondazione Don Carlo Gnocchi Onlus Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇧🇪 BE🇮🇹 IT🇵🇹 PT🇨🇭 CH

**Who might be able to join this trial:** - You must be 18 years of age or older (men and women are both eligible) - You have been diagnosed with atherosclerotic cardiovascular disease (a condition where the arteries are narrowed or hardened due to plaque buildup), such as a heart attack, chronic heart disease, or hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07255469 · University Hospital, Bordeaux Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 March 2027
🇫🇷 FR

Who might be able to join this trial: - Children aged 15 years old or younger - Children who are staying in a pediatric intensive care unit after heart surgery - Children whose doctor has ordered a fluid expansion (a specific amount of fluid given through a drip) of 10ml per kilogram of body weight - Children whose doc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07257198 · Montreal Heart Institute Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2030
🇨🇦 CA

**Who might be able to join this trial:** - People aged 18 or older - People who are currently hospitalised for a specific type of heart attack (called a "Type 1 MI"), as defined by established medical guidelines - People who have had a coronary angiogram (an imaging test to look at the heart's arteries) performed duri...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07257289 · Nantes University Hospital Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 3 February 2036
🇫🇷 FR Martinique Reunion

Who might be able to join this trial: - People who have been diagnosed with a hereditary (inherited) heart disease - Family members of patients who have an inherited heart condition - People who have been referred to the specialist centre because doctors suspect they may have an inherited heart rhythm problem or an inh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07259278 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older who have been diagnosed with coronary heart disease - People whose heart condition has been assessed as low-risk for cardiovascular events during physical activity, and who also score as low-risk on a standard heart risk assessment tool called the GRAC...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07266675 · Mackay Memorial Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇹🇼 TW

Who might be able to join this trial: - Adults who survived a hospital stay where they experienced cardiogenic shock (a serious condition where the heart suddenly cannot pump enough blood to meet the body's needs) Who may not be able to join: - People under 18 years of age - People (or their family members) who are no...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07268859 · Acibadem University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 January 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People aged between 18 and 65 years old - People without severe hearing or vision problems - People who can speak and understand Turkish - People who are easy to communicate with - People experiencing acute coronary syndrome (a serious heart condition) for the first time - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07270536 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇧🇪 BE

**Who might be able to join this trial:** - You are willing to take part and have given your written agreement before any screening tests begin - You are at least 18 years old - You have been diagnosed with heart failure where the heart's pumping strength is relatively preserved (sometimes called HFpEF), confirmed by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07277686 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older. - People who have been diagnosed with diabetes. - People who have been diagnosed with high blood pressure. - People who are older than 65 years of age. *(At least one of the three conditions above must apply.)* Who may not be able to joi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07281014 · Yale University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 August 2027
🇺🇸 US

Who might be able to join this trial: - People who have chronic, stable heart failure with symptoms that are mild or absent (known as NYHA Class I or II), and whose fluid levels are well managed - People whose kidneys are functioning above a certain level (confirm with trial site for exact threshold) - People whose blo...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07281859 · University of Padova Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 June 2027
🇮🇹 IT

Who might be able to join this trial: - People who have had a specific type of heart device (called an ICD or CRT-D) newly implanted within the last year, where the device includes atrial sensing and a remote home monitoring system. - People with a documented diagnosis of heart failure, whether caused by blocked arteri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07284446 · Lithuanian University of Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 December 2028
🇱🇹 LT

Who might be able to join this trial: - People who are in hospital mainly because of a worsening of their chronic heart failure (CHF) - People who are medically stable enough to understand and agree to take part in the study - People who do not have severe memory or thinking difficulties that would make completing ques...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07291219 · Fondazione IRCCS Policlinico San Matteo di Pavia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇮🇹 IT

Who might be able to join this trial: - People who are willing to sign a written consent form agreeing to take part in the study's evaluations - People who have been diagnosed with chronic heart failure (a condition where the heart doesn't pump blood as well as it should) - People who are 18 years of age or older Who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07291609 · Azienda Ospedaliera "Sant'Andrea" Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇮🇹 IT

Who might be able to join this trial: - People who are older than 18 years of age - People who have suspected or confirmed long-term heart artery disease and are having a CT scan of the heart's arteries - People for whom a doctor has recommended an invasive procedure to look inside the heart's arteries (a procedure don...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07292909 · Hotel Dieu de France Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2027
🇱🇧 LB

Who might be able to join this trial: - People with stable coronary artery disease (a long-term heart condition affecting the blood vessels of the heart) who are scheduled for a planned procedure to open a blockage in a natural coronary artery that has not been treated before. Who may not be able to join: - People who...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07293832 · Aristotle University Of Thessaloniki Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇬🇷 GR

**Who might be able to join this trial:** - People aged between 18 and 80 years old - People whose heart tracing (ECG) shows a specific pattern of abnormality (called ST-segment elevation of 2mm or more in at least 2 connected areas of the heart) lasting more than 30 minutes - People where the estimated time between w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07293923 · Magenta Medical Ltd. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 30 January 2028
🇬🇪 GE🇮🇱 IL

**Who might be able to join this trial:** - People who have been in cardiogenic shock (a serious condition where the heart cannot pump enough blood) for less than 24 hours. - People whose heart's pumping strength falls within a specific range — confirmed by an ultrasound of the heart on the day of enrolment (confirm w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07296081 · University of Coimbra Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇵🇹 PT

**Who might be able to join this trial:** - People aged 18 or older - People who have signs and symptoms of heart failure - People who fall into one of two heart conditions: (1) those with a preserved pumping function of the heart (at least 50%), along with evidence of the heart not relaxing properly, elevated heart-r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07296744 · Supira Medical Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are medically stable and are scheduled for a high-risk heart procedure (not an emergency) where the medical team has decided that extra heart support during the procedure is needed. - People who have given their own consent to join, or whose legal representative ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07303439 · Royal College of Surgeons, Ireland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 December 2026
🇮🇪 IE

**Who might be able to join this trial:** - People who have been diagnosed with either a recent (acute) or ongoing (chronic) heart artery problem (coronary syndrome) - People who have been diagnosed with diabetes - People who are having a procedure called PCI (a treatment to open blocked heart arteries) on a new block...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07312318 · China-Japan Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who are scheduled for or have already had a procedure to open blocked heart arteries (called a PCI, or percutaneous coronary intervention) - People from whom a blood sample can be collected at the start of the trial - People who ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07313657 · Bruyère Health Research Institute. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who are at risk of heart failure due to conditions such as an irregular heartbeat, blocked heart arteries, a previous heart attack, treated high blood pressure, or a heart muscle condition — or who have been diagnosed with heart failure. - People who are currently tak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07318103 · Fujian Shengdi Pharmaceutical Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older at the time of signing the consent form, of any gender - People who have been admitted to hospital for heart failure within the 72 hours before being enrolled in the trial - People who, at the time of assessment, have heart failure symptoms (such as b...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07335510 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with heart failure where the heart's pumping strength is significantly reduced (specifically, the heart pumps out 35% or less of its blood with each beat), with this diagnosis confirmed within the past 12 months - People whose heart failure sym...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07343804 · Postgraduate Institute of Dental Sciences Rohtak Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇮🇳 IN

**Who might be able to join this trial:** - People aged 30 or older who have been diagnosed with stable coronary artery disease (a long-term heart condition affecting the arteries) and a specific type of dental root infection called chronic apical periodontitis. - People whose heart condition meets the definition used...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07347925 · Future University in Egypt Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 April 2026
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 or older, of any gender - People whose heart is pumping at less than 40% of its normal capacity (a measurement called ejection fraction, or EF) Who may not be able to join: - People whose heart is pumping at 40% or more of its normal capacity (ejection fraction of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07354399 · University Medical Centre Ljubljana Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇸🇮 SI

Who might be able to join this trial: - People who have been diagnosed with coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked) - People who have been in a stable health condition for a period of time — specifically, at least 1 month since a heart attack or a non-emer...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07354568 · Centre Hospitalier Universitaire, Amiens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇫🇷 FR

Who might be able to join this trial: - People who are over 18 years of age - People who have been admitted to an intensive care unit for a serious heart-related condition where the heart is not pumping enough blood (cardiogenic shock), at a severity level meeting a specific medical threshold (at least SCAI stage C — c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07354646 · Chinese Academy of Medical Sciences, Fuwai Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older who have been clinically diagnosed with a heart muscle disease, based on current international medical guidelines - People diagnosed with a type of heart muscle disease called cardiomyopathy (including hypertrophic, dilated, restrictive, or arrhythmog...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07355192 · Medical College of Wisconsin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇺🇸 US

Who might be able to join this trial: - People who have a history of coronary artery disease, meaning they have had at least one of the following: a heart attack, a coronary stent, a procedure to open blocked heart arteries (PCI), heart bypass surgery (CABG), a significant narrowing of a heart artery (at least 50%), or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07362966 · Shenyang Northern Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2027
🇨🇳 CN

Who might be able to join this trial: - People aged between 40 and 85 years old - People who were hospitalised in the past 30 to 90 days for a documented acute coronary syndrome (a serious heart event such as a heart attack or unstable chest pain) - People who, during that hospitalisation, had either a procedure to ope...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07366684 · Clinical Center Niš Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇷🇸 RS

Who might be able to join this trial: - People who are 75 years of age or older - People who have been diagnosed with a type of heart condition called acute coronary syndrome, which includes heart attacks (STEMI or NSTEMI) or severe chest pain caused by reduced blood flow to the heart (unstable angina) - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07369856 · Cardiology Research UBC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇨🇦 CA

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with heart failure according to the Universal Definition (confirm with trial site) - People who are currently taking loop diuretics (a type of fluid/water pill) - People who live within the VCH or PHC health...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07372040 · Tanta University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 February 2027
🇪🇬 EG

**Who might be able to join this trial:** - Adults aged 18 years or older (male or female) - People who have been admitted to hospital with a diagnosis of acute worsening heart failure, with at least one sign of fluid buildup in the body — such as swelling (edema), fluid in the abdomen (ascites confirmed by ultrasound)...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07373041 · Queen's University, Belfast Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 November 2027
🇬🇧 GB

**Who might be able to join this trial:** **Carers (people providing unpaid support to someone with heart failure):** - People aged 18 years or older - People who are physically and mentally able to use a digital device, have conversations with others, and read written materials - People who regularly provide unpaid c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07378163 · Xijing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇨🇳 CN

Who might be able to join this trial: - People who have had a heart artery blockage (either sudden or long-term) and have been treated with a procedure to open the blocked artery (known as a stent procedure or balloon procedure) - People who are able to understand the purpose of the trial and are willing to answer a pr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07381803 · Second Affiliated Hospital, School of Medicine, Zhejiang University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 years or older. - People who are able to verbally show they understand the risks, benefits, and treatment options involved, and who (or whose legal representative) are willing to sign a written consent form before the trial begins. - People who have had an acute he...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07382284 · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medic... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been diagnosed with severe, end-stage heart failure that has not responded to the best available medical treatments - People who are already scheduled to have a heart pump device (called an LVAD) implanted as part of their norm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07385417 · Cardioangiologisches Centrum Bethanien Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 April 2026
🇩🇪 DE

Who might be able to join this trial: - People who are seeking emergency treatment, including those presenting to an emergency room - People who have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that starts and stops on its own) according to current medical guidelines - People who h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07388342 · Universitair Ziekenhuis Brussel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇧🇪 BE

Who might be able to join this trial: - Adults aged 18 or older who have had a cardiac arrest (either inside or outside of a hospital) and whose heart has restarted on its own after treatment. - Informed consent has been given by the patient or their legal representative before any heart artery procedure is performed....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07388745 · Kutahya Health Sciences University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - You are between 45 and 85 years old - You are already scheduled for planned (non-emergency) heart bypass surgery - Your overall health has been rated at a certain level by your anesthesia team (confirm with trial site for what this means for you) - You are willing and able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07390903 · Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇮🇹 IT Turkey (Türkiye)

Who might be able to join this trial: - People who are over 18 years old. - People who are scheduled for planned (non-emergency) heart surgery that requires the use of a heart-lung bypass machine. - People who have given written consent to take part in the trial. - People whose planned surgery falls into one of these c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07397351 · Research Institute of Geroprotective Technologies Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 October 2026
🇷🇺 RU

**Who might be able to join this trial:** - People who have coronary artery disease where one or more heart arteries are significantly narrowed, and who have been recommended for a planned (non-emergency) procedure to open the artery and place a stent — this includes people with stable chest pain or heart disease caus...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07402239 · United Innomed(Shanghai) Limited Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with chronic (long-term) heart failure - People who are already receiving the recommended standard treatments for heart failure, including both medications and any relevant devices - People whose heart pumping strength...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07420582 · Kocaeli City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
Turkey (Türkiye)

Who might be able to join this trial: - Adults between 18 and 80 years of age. - People scheduled for a planned (non-emergency) heart bypass surgery performed for the first time, using a heart-lung machine, without any other heart procedures done at the same time. Who may not be able to join: - People having emergency...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07427472 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 June 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who have been diagnosed with a hereditary condition called heterozygous familial hypercholesterolaemia (a genetic condition that causes high cholesterol levels) - People aged between 30 and 60 years old - People who had both a coronary calcium score scan and a coronary...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07429227 · Casa di Cura Dott. Pederzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇮🇹 IT

Who might be able to join this trial: - People who are aged between 30 and 70 years old - People who have been diagnosed with Acute Coronary Syndrome (a serious heart condition where blood flow to the heart is suddenly reduced or blocked) - People who are willing and able to sign a consent form agreeing to take part W...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07439159 · Istanbul University - Cerrahpasa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been admitted to hospital due to a sudden worsening of heart failure - People whose treating heart specialist has determined that diuretic medication given through a drip (intravenously) is needed - People whose heart failure is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07443670 · Noah Labs Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇩🇪 DE🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who have already had a pulmonary artery (PA) pressure sensor successfully implanted and are being monitored at a participating study centre - People who are willing to record a short, set piece of text every day for 3 months using...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07444398 · Khawaja Danish Ali Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 March 2026
🇵🇰 PK

**Who might be able to join this trial:** - You have been diagnosed with a serious form of heart failure where your heart is not pumping well (specifically, where the heart pumps out 45% or less of its blood with each beat), AND you are experiencing severe breathlessness or fatigue that limits daily activities, or wors...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07444697 · Kırıkkale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Male patients between 30 and 75 years of age - People who have recently had a heart procedure called a coronary angioplasty (where a blocked artery in the heart is reopened), done for either a heart attack or stable chest pain caused by reduced blood flow to the heart - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07444957 · Fundación Interhospitalaria para la Investigación Cardiovascular FIC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 July 2027
🇪🇸 ES

Who might be able to join this trial: - People aged 18 or older who have coronary artery disease and, in their treating doctor's judgment, need treatment of a blockage in a heart artery or heart bypass graft using a specific drug-coated balloon device. - People who are willing and able to sign a written consent form ag...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07449377 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years old or older - You have come to the emergency department with sudden shortness of breath, and there is no other clear reason found for it (such as a collapsed lung, a new lung infection, a heart attack, or Covid-19) - You are affiliated with the French social...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07451457 · Gottsegen National Cardiovascular Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇭🇺 HU

Who might be able to join this trial: - Adults (18 years or older) who have been admitted to hospital for heart failure, or who are being treated at an outpatient heart failure clinic, at one of two participating centres in Hungary (Gottsegen National Cardiovascular Center or the University of Debrecen) - People who ta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07451522 · Primorsky Regional General Hospital #1 Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇷🇺 RU

**Who might be able to join this trial:** - People aged between 18 and 75 years - People who are scheduled for coronary artery bypass graft (CABG) heart surgery - People with a body weight that falls within a healthy to moderate range (BMI between 18.5 and 35 kg/m²) - People who are in generally good to moderate overal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07451873 · Josip Juraj Strossmayer University of Osijek Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2029
🇭🇷 HR

Who might be able to join this trial: - Adults aged 18 or older of any gender - People of Caucasian (white European) background - People scheduled for a planned (non-emergency) heart bypass surgery, known as coronary artery bypass grafting (CABG) - People who have given their written agreement to take part in the trial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07454070 · Jing Han Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with a serious heart condition called Acute Coronary Syndrome (ACS), such as a heart attack or unstable chest pain - It has been between 14 days and 12 months since you had a successful procedure to open a blocked he...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07460960 · Lomonosov Moscow State University Medical Research and Educational Cen... Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
🇷🇺 RU

**Who might be able to join this trial:** - Men between the ages of 40 and 65 who are sexually active - People assessed as having a high or very high risk of a heart attack or stroke, based on a specific cardiovascular risk scoring tool called SCORE2 - People who have not taken statin medications (cholesterol-lowering...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07465653 · Novartis Pharmaceuticals Phase 1 · 2 countries Recruiting
Recruiting Phase 1 Est. completion 24 September 2026
🇨🇦 CA🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older, both men and women - People with a moderate level of heart failure symptoms, classified as NYHA functional class II or III (meaning symptoms appear during ordinary or minimal physical activity) (confirm with trial site) - People whose heart pumps out...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07472959 · Istanbul University - Cerrahpasa Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2026
Turkey (Türkiye)

Who might be able to join this trial: - Adults between 18 and 80 years of age - People classified as ASA III, meaning they have a serious but stable ongoing medical condition (confirm with trial site) - People who are already scheduled for a planned (non-emergency) coronary artery bypass grafting (heart bypass) operati...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07476703 · Danderyd Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇸🇪 SE

Who might be able to join this trial: - People who are already participating in the main general SCAPIS re-examination study in Stockholm. Who may not be able to join: - People who are unable to give their informed consent to participate. Important: Always verify eligibility with the trial site directly before applyi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07476859 · Fundación para la Investigación del Hospital Clínico de Valencia Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 April 2028
🇪🇸 ES

Who might be able to join this trial: - People who are 65 years of age or older - People who were admitted to hospital for a confirmed heart attack or serious cardiac event within the past 15 days - People who were found to have low iron levels at the time of that hospital admission or within 15 days after the heart ev...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07478003 · Thomas Engstrom Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 20 April 2031
🇩🇰 DK

**Who might be able to join this trial:** - Adults aged 18 or older, including women who are able to become pregnant - People who have had a sudden onset of chest pain that started less than 24 hours ago - People whose heart tracing (ECG) shows a specific type of heart attack (called STEMI), identified by one of sever...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07482462 · University Medical Centre Ljubljana Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇸🇮 SI

**Who might be able to join this trial:** - Healthy adults aged 18–35 years, without any known acute or chronic illness, who are non-smokers, have a body mass index (BMI) between 20 and 24.9, and have a negative result on a standing blood pressure test (orthostatic test) - Adults aged 60 or older who have high blood p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07492498 · Jiangsu Taizhou People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇨🇳 CN

Who might be able to join this trial: - The trial involves village clinics that are willing and able to provide combined care to their patients who have atrial fibrillation (an irregular heartbeat condition) - The village clinic serves patients from 3 to 5 nearby villages, with the same village doctor caring for all at...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07492537 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇮🇹 IT

**Who might be able to join this trial:** - You are 18 years of age or older - You have been admitted to hospital for your **first-ever heart attack** (either a STEMI or NSTEMI type) within the last 7 days - You have completed a short mood/depression questionnaire (called the PHQ-9) at the screening visit - You have sc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07498231 · Medical University of Bialystok Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇵🇱 PL

**Who might be able to join this trial:** - People who have a long-term, stable heart condition known as chronic coronary syndrome - People who experience chest pain or similar symptoms rated above the mildest level on a standard scale (confirm with trial site) - People whose heart has been shown to have reduced blood...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07511257 · Instituto Nacional de Cardiologia Ignacio Chavez Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2029
🇲🇽 MX

**Who might be able to join this trial:** - Adults between 18 and 80 years old (any sex) who are in the hospital with a heart attack or similar urgent heart condition - The heart attack or urgent heart condition must have happened within the last 7 days before joining, shown by symptoms, an abnormal blood test for hea...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07512778 · SUK MIN SEO Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇰🇷 KR

**Who might be able to join this trial:** - People aged 19 years or older - People who have been diagnosed with unstable angina (chest pain at rest or with minimal activity), or a heart attack, including both NSTEMI and STEMI types - People with coronary artery disease where at least one artery is blocked by more than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07514962 · Cardiocentro Ticino Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇨🇭 CH

Who might be able to join this trial: **Historical control group (looking back at past patients):** - Adults aged 18 or older - People who have had a specific type of heart bypass surgery (called MIDCAB) using an internal chest artery to bypass a blocked heart artery **Prospective group (new participants going forwar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07518030 · Azienda Unita Sanitaria Locale di Piacenza Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇮🇹 IT

Who might be able to join this trial: - People who are aged 18 or older - People who have recently been diagnosed with a type of heart failure called HFrEF (where the heart's pumping function is reduced), whether that diagnosis was made in hospital or at a clinic - People who have not yet started any standard heart fai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07518862 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇨🇦 CA

Who might be able to join this trial: - People who are older than 18 years of age - People who are currently receiving a type of oxygen therapy delivered through a nasal tube that uses high-flow air (called High-Flow Nasal Cannula Therapy) Who may not be able to join: - People whose oxygen concentration setting is 90%...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07526766 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with Spontaneous Coronary Artery Dissection (SCAD) — a type of tear in a heart artery — and/or Fibromuscular Dysplasia (FMD) — a condition affecting the walls of arteries — at least 2 months after the event and currently not experiencing chest pain....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07528482 · Ankara University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 4 May 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who are 18 years of age or older - People who have not had open heart surgery in the past - People who have not taken any pain relief medication in the 4 hours before the procedure - People who have a pain score of 3 or higher on a standard pain scale (where patients rate...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07536802 · National Institute of Cardiovascular Diseases, Pakistan Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 May 2026
🇵🇰 PK

Who might be able to join this trial: - People who are having a heart attack of a specific type (called STEMI) and are being treated with an emergency procedure to open blocked heart arteries (called primary PCI) - People of any gender who are 18 years of age or older Who may not be able to join: - People whose heart...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07537296 · Nanjing First Hospital, Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who have had a heart attack within the last 4 weeks, including either a major type (called STEMI) or a less severe type (called NSTEMI) - People who have had a procedure to open a blocked heart artery (called PCI) as treatment for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07541768 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇭 CH

Who might be able to join this trial: - People who are medical residents working in general internal medicine - People who have basic ultrasound skills, meaning they have completed a beginner ultrasound training component (called POCUS component 1) or have performed 200 or more scans - People who are working at the tri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07550790 · Seoul National University Bundang Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2029
🇰🇷 KR

Who might be able to join this trial: - Adults aged 20 years or older - People who visited an emergency department or were admitted to hospital for sudden (acute) heart failure, with signs of fluid build-up in the body - People who are already planned to have a contrast-enhanced CT scan (a type of detailed X-ray using...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07551167 · Chengdu Suncadia Medicine Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are a generally healthy man or woman between 18 and 65 years old - Men weigh at least 50 kg but less than 90 kg, or women weigh at least 45 kg but less than 90 kg, with a BMI between 19 and 26 kg/m² - Your health checks at the start of the study show no significant medica...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07552948 · Tomsk Cardiology Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇷🇺 RU

Who might be able to join this trial: - People who have blockages in three heart arteries, including a specific artery called the circumflex artery, where the blockage is at least 70% and the artery is large enough to treat (at least 1.5 mm wide) - Women aged 18 years or older - People who have signed a form agreeing t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07560436 · King's College London Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2028
🇬🇧 GB

Who might be able to join this trial: - People who have been diagnosed with a specific type of heart failure called HFpEF (heart failure with preserved ejection fraction), as defined by European heart specialist guidelines - People whose heart failure causes symptoms rated as moderate to severe (meaning daily activitie...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07560592 · Maya Guglin, MD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 November 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People admitted to hospital for heart failure within the last 24 hours Who may not be able to join: - People who have high blood pressure (above 150/90 mmHg) at the time of hospital admission - People with advanced kidney failure who are currently...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07574593 · Foundry Innovation & Research 1, Limited (FIRE1) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2029
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 years or older. - People who are willing and able to give formal consent to take part, attend follow-up visits, and follow the study instructions. - People who have been diagnosed with heart failure for more than 90 days, have been on the best tolerated medica...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07577596 · University of Aarhus Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2027
🇩🇰 DK

**Who might be able to join this trial:** - People who have been diagnosed with acute heart failure where the body is retaining too much fluid (known as volume overload) - People who have at least one physical sign of excess fluid buildup in the body (such as swelling) - People who are expected to need heart failure tr...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07577609 · University of Galway Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 December 2032
🇮🇪 IE

Who might be able to join this trial: - Adults who are 18 years of age or older - People who are already scheduled to have a cardiac CT scan as part of their normal medical care - People who are able to understand the study and are willing to agree to participate Who may not be able to join: - People who have a histor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07604103 · University of Brawijaya Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 August 2026
🇮🇩 ID

**Who might be able to join this trial:** - You are a male adult under 65 years old. - You have a history of being a regular smoker. - You have been diagnosed with both a heart attack or serious heart condition (Acute Coronary Syndrome) and pneumonia, confirmed through medical tests, blood work, and imaging. - Your con...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07613996 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇨🇳 CN

Who might be able to join this trial: - People who have stable chest pain (angina) or are suspected of having coronary heart disease (a condition affecting the blood vessels of the heart). - People who are already scheduled to have a coronary angiography (a procedure that takes images of the heart's blood vessels) alon...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07619144 · Medical University of Vienna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 January 2029
🇦🇹 AT

Who might be able to join this trial: - Adults who were treated for a serious heart condition called cardiogenic shock and had a specific heart support device (called an Impella 5.5) used during their care - People whose detailed device data (downloaded from the clinical machine) and intensive care unit digital health...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07621367 · The Second Hospital of Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 April 2031
🇨🇳 CN

Who might be able to join this trial: - You have been diagnosed with a condition where reduced blood flow or oxygen to the intestines is causing problems, such as ischemic bowel disease or heart failure, and you experience repeated or ongoing stomach pain, bloating, and/or difficulty having bowel movements. - You are a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07632586 · FineHeart Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇿 CZ🇫🇷 FR

Who might be able to join this trial: - People aged between 18 and 80 years old (inclusive). - People who are willing and able to provide written consent to take part. - Women who are able to become pregnant must agree to use adequate contraception during the trial. - People with suitable mental and thinking abilities...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07636642 · University of Edinburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇬🇧 GB

Who might be able to join this trial: - People who are 18 years of age or older. - People whose attending doctor suspects they may be having a heart attack or related heart condition (acute coronary syndrome). - People who have had at least one blood test measuring a heart protein called cardiac troponin, using a speci...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07649330 · Siou-Pin Huang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇹🇼 TW

Who might be able to join this trial: - Adults aged 18 or older - People who are able to speak and follow instructions - People who have been diagnosed by a doctor with a heart artery condition, a heart valve condition, or a disease affecting the large blood vessel leaving the heart (the aorta) - People who are schedul...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07650669 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2036
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 85 years of age. - People who have been diagnosed with heart failure, or who have been identified as being at risk of developing heart failure. - People who already own, or are willing to get, a compatible consumer smartwatch or fitness tracker (such as a Fi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07656259 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older who have been admitted to a cardiac intensive care unit and need a breathing machine (mechanical ventilator) for more than 12 hours *The trial also includes specific subgroups for additional research questions. These include people with:* - A serious...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07657624 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2031
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with coronary heart disease, shown by at least one of the following: a scan or imaging test showing a significant blockage (50% or more) in at least one major heart artery; a previously confirmed diagnosis of coronary h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07660419 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with mild or moderate narrowing of one or more coronary arteries (the blood vessels supplying the heart), where a buildup of plaque is causing less than 70% blockage - People aged between 18 and 70 years - People who did not experience chest pai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07662317 · Second Affiliated Hospital, School of Medicine, Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2031
🇨🇳 CN

Who might be able to join this trial: - People who are scheduled to have heart surgery between May 1, 2026 and December 31, 2031 Who may not be able to join: - People who do not agree to give their formal consent to take part in the study Important: Always verify eligibility with the trial site directly before applyi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07671742 · Acorai AB Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇸🇪 SE

Who might be able to join this trial: - People who are 18 years of age or older - People who have been admitted to hospital primarily because of heart failure, meaning they have new or worsening heart failure symptoms with signs of fluid buildup in the body that require starting or increasing heart failure treatment -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07680634 · St. Antonius Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2030
🇳🇱 NL

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with heart failure according to current European Society of Cardiology (ESC) guidelines - People who receive outpatient care at one of the seven hospitals participating in this trial - People who have enough digital s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07687186 · Tasly Pharmaceutical Group Co., Ltd Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 22 June 2028
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 to 80 years old at the time of signing the consent form - People who have been diagnosed with both coronary heart disease and chronic heart failure - People whose heart failure has been assessed as matching a Traditional Chinese Medicine (TCM) pattern describe...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07713017 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇵🇰 PK

Who might be able to join this trial: - People of any gender (male or female) may be considered. - People who have had a coronary artery bypass graft (CABG) — a type of heart surgery — that went smoothly, with no complications during or after the operation. - People who are willing to take part in a Phase II cardiac re...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Heart Disease. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

The Heart Foundation is the national body for heart health.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.